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Clancy: Knowledge Is Power: The Federal Government Must Require Companies

NOTE
KNOWLEDGE IS POWER: THE FEDERAL
GOVERNMENT MUST REQUIRE COMPANIES TO
TELL MENSTRUATORS THE INGREDIENTS IN
PERIOD PRODUCTS
I.

INTRODUCTION

Imagine being a twelve-year-old girl experiencing her period for
the first time. 1 Like most women2 in the United States, 3 you begin using
feminine hygiene products 4 ("menstrual products" or "period products").5 Four years later, at age sixteen, you begin experiencing longer,
1.

See Steven M. Weissberg & Melvin G. Dodson, Recurrent Vaginal and Cervical Ulcers

Associated with Tampon Use, 250 J. AM. MED. ASS'N 1430, 1431 (1983).
2. In order to reflect the relevant literature, this Note will primarily use the term "women" to
refer to people who use menstrual products. See ALEXANDRA SCRANTON, CHEM FATALE:
POTENTIAL HEALTH EFFECTS OF TOXIC CHEMICALS IN FEMININE CARE PRODUCTS 9 (2013),
https://womensvoices.org/wp-content/uploads/2013/1 1/Chem-Fatale-Report.pdf
(reporting
the

health risks period products create for women). However, it is important to note that women are not
the only group of people that menstruate and use period products. See S.E. Frank & Jac Dellaria,
Navigating the Binary: A Visual Narrative of Trans and Genderqueer Menstruation, in TIHE
PALGRAVE HANDBOOK OF CRITICAL MENSTRUATION STUDIES 75 (Chris Bobel et al. eds., 2020).
Therefore, the term "menstruator" will also be used to identify people who menstruate. See Anureet,
Menstruators: A Gender Neutral & Inclusive Term for All Our Period Conversations, SHE THE

PEOPLE (Aug. 17, 2020), https://www.shethepeople.tv/home-top-video/menstruators-a-genderneutral-inclusive-term-for-all-our-period-conversations ("Menstruators, evidently means, people
who menstruate/have periods. This is a much more inclusive term used by informed health care
providers, because it includes transgender men and non-binary people as well."). See Sarah E.
Frank, Queering Menstruation: Trans and Non-Binary Identity and Body Politics, 90 SOCIO.

INQUIRY 371, 376-77 (2020), for an inclusive discussion of experiences from people who
menstruate and do not identify as female.
3. See The Ultimate Guide to

Feminine Hygiene, DUQ. UNIV. SCH. NURSING,
https://onlinenursing.duq.edu/master-science-nursing/the-ultimate-guide-to-femininehygiene/#:-:text=About%2020%20to%2050%20percent,to%20Women's%20Voices%20for%20Ear
th (last visited Aug. 1, 2021) (discussing the percentage of women using period products in the
United States).
4. See Weissberg & Dodson, supra note 1, at 1431.
5. See Elizabeth Licorish, Stop Calling Them "Feminine Hygiene Products," BUSTLE (Jan.
11,
2017),
https://www.bustle.com/articles/94989-why-we-need-to-ditch-the-term-femininehygiene-products. Historically in the United States, the industry standard for products used during
menstruation, like tampons and sanitary pads, have been referred to as "feminine hygiene products."
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6
painful periods and seek the medical advice of a doctor. After an
examination and a few tests, your doctor discovers that you have a
vaginal ulcer and recommends that you stop using tampons for the time
being.' After discontinuing the use of tampons, your ulcer clears up one
month later.8 Fourteen months later, you start using tampons again, and
9
the doctor discovers another ulcer on your right lateral vaginal wall.
Once again, your doctor recommends that you discontinue the use of
tampons, and your ulcer goes away one month later.' 0 Since that time,
you have not experienced another vaginal ulcer.' It is not uncommon
for menstruators in the United States to experience health problems, like
vaginal ulcers, as a result of using popular period products like
tampons. 12
The average woman experiences approximately 456 periods
throughout her lifetime.' 3 This means a woman uses around 16,000
tampons 14 and spends over $26,000 on period products during her
lifetime."' In the United States, only two states require manufacturers to

See id. However, the term feminine hygiene product is restrictive and does not acknowledge the
audience that uses these products. See id. Therefore, this Note will refer to these products as
menstrual products or period products to recognize the shift toward gender identity inclusivity in
sexual health. See Kells McPhillips, Why We Need Genderless 'Feminine Hygiene Products', WELL
See Claire
+ GOOD (Oct. 24, 2019), https://www.wellandgood.com/feminine-hygiene-products.
McCormack, Productsfor People with Vaginas: The Shift Toward Gender Identity Exclusivity in
2019),
23,
(May
INDEP.
BEAUTY
Care,
Period
and
Health
Sexual
https://www.beautyindependent.com/products-people-vaginas-gender-identity-inclusivity-sexualhealth-period-care, for further discussion of gender identity inclusivity in sexual health.
6. See Weissberg & Dodson, supra note 1.
7. See id.
8. See id.
9. See id.
10. See id.
11. See id.
12. See id.; Tampon Safety and Research Act of 1997, H.R. 2900, 105th Cong. (1997);
SCRANTON, supra note 2, at 20 (analyzing the health problems many women experience in the
United States as a result of using period products).
13.

Jessica Kane, Here's How Much a Woman's Period Will Cost Her Over a Lifetime,

HUFFPOST (Dec. 6, 2017), https://www.huffpost.com/entry/period-cost-lifetimen_7258780.
14. Jane Sheffer, New Tampon Testing Confirms Need for Ingredient Disclosure!, WOMEN'S
VOICES FOR THE EARTH (June 5, 2018), https://www.womensvoices.org/2018/06/05/new-tampontesting-confirms-need-for-ingredient-disclosure (reporting the results of a new study observing
tampon usage). This number does not include the other period products women use during their
lifetime. See id.; Robin Danielson Feminine Hygiene Product Safety Act of 2017, H.R. 2379, 115th
Cong. § 2(2) (2017) (describing a 2017 congressional study that found women use around 16,800
tampons during their lifetime).
15. See Rachel Moss, Women Spend More Than
HUFFPOST
Reveals,
Study
Lifetime,

618,000

on Having Periods in Their
(Sept.

3,

2015),

https://www.huffingtonpost.co.uk/2015/09/03/women-spend-thousands-on-periods-tampontaxn_8082526.html.
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disclose the ingredients in menstrual products.1 6 Pursuant to the Federal
Food, Drug, and Cosmetic Act,' 7 the Food and Drug Administration
("FDA") does not require companies to label menstrual products with
their ingredients because menstrual products are classified as medical
devices.' 8 Therefore, under current federal law, menstruators do not
know the ingredients in their period products.19
Multiple studies that tested the ingredients in menstrual products
revealed that they contain toxins and other chemicals that are dangerous
to menstruators' health.2 0 These ingredients have been linked to cancer,
as well as many other adverse health effects. 21 Yet, menstruators
continue to use these products in the most absorbent part of their body
without knowing their dangerous ingredients.22
This Note will argue that the Federal Food, Drug, and Cosmetic Act
must be amended to require companies to label menstrual products with
their ingredients and associated health risks and impose a penalty on
companies that do not comply with the requirements.23 This will ensure
that menstruators know the ingredients in their period products and the
associated health risks, which will allow them to choose products that
are less likely to put their health in danger.24 In Part II, this Note will

16. Estrella Jaramillo, Cuomo Signs Bill Making New York the First State to Mandate
Ingredient
List
for
Tampons,
FORBES
(Oct.
11,
2019,
3:44
PM),
https://www.forbes.com/sites/estrellajaramillo/2019/10/ 1I/cuomo-signs-bill-new-york-first-state-tomandate-ingredient-list-for-tampons/#7f96ef5c2b77 (stating that New York was the first state in the
country to pass a law requiring companies to disclose the ingredients in menstrual products).
17. 21 U.S.C. § 301 et seq. (2018).
18. SCRANTON, supra note 2, at 8; Joan Raymond, How Safe Is Your Tampon?, TODAY,
https://www.today.com/health/how-safe-your-tampon-t112885
(Aug. 14, 2018, 2:49 PM)
(explaining that menstrual product companies do not have to label the products with their
ingredients because the Food and Drug Administration ("FDA") classifies them as medical devices).
19. See Rachel Polansky, Do You Know What's in Your Tampon?, WOMEN'S VOICES FOR THE
EARTH (Feb. 6, 2019), https://www.womensvoices.org/2019/02/06/do-you-know-whats-in-yourtampon/#:~:text=The%20answer%20is%201ikely/a20no,both%20sides%20of/20the%20issue.&te
xt=Women's%20Voices%2For%2OThe%2OEarth%20is%20a%20non%2Dprofit%2Othat,makers%
20to%20be%20more%20transparent (explaining that women do not know the ingredients in their
tampons because the federal government does not require companies to disclose the ingredients).
20. SCRANTON, supra note 2, at 20; Tampon Safety and Research Act of 1997, H.R. 2900,
105th Cong. (1997); What's in Your Tampon? 2018 Tampon Testing Results, WOMEN'S VOICES
FOR THE EARTH (2018), https://www.womensvoices.org/menstrual-care-products/whats-in-yourtampon (explaining the findings of studies that tested the ingredients in menstrual products and
revealed toxic chemicals).
21. SCRANTON, supra note 2, at 20; H.R. 2900 (discussing the health risks menstrual products
create for the women who use them).
22. See SCRANTON, supra note 2, at 3-4.

23. See infra PartlV.
24. See On Day of the Girl, Governor Cuomo Signs Legislation to Make New York the First
State in the Nation to Require Disclosure of Ingredients in Menstrual Products, N.Y. ST. (Oct. 11,

2019),

https://www.governor.ny.gov/news/day-girl-governor-cuomo-signs-legislation-make-new-
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discuss types of menstrual products and the reason they are used."
Furthermore, Part II will discuss the ingredients found in menstrual
products, how these ingredients create a dangerous risk to menstruators'
26
health, and the unique structure of the vagina. Subsequently, Part III of
this Note will discuss the Federal Food, Drug, and Cosmetic Act that
regulates the current labeling and disclosure requirements for menstrual
products, as well as the FDA's authority regarding ingredient disclosure
requirements.27 This Part also separately assesses the New York and
California Menstrual Products Right to Know Acts, as well as a
proposed federal bill, that requires menstrual product manufacturers to
28
disclose the ingredients in their products. Part IV will propose a federal
approach, amending the Federal Food, Drug, and Cosmetic Act to
require companies to disclose the ingredients in menstrual products,
include a warning of the associated health risks, and impose a monetary
29
penalty on companies that do not comply with the requirements.
Finally, Part V of this Note will conclude and reiterate the importance of
bringing awareness to the health risks that menstrual products create for
menstruators under current federal law because companies are not
30
required to disclose the ingredients in menstrual products.
II.

MENSTRUAL PRODUCTS IN THE UNITED STATES

Part II of this Note discusses menstrual products in the United
States. 31 Subpart A defines and discusses types of menstrual products
and how they are classified under current federal law. 32 Subpart B
identifies the undisclosed, dangerous ingredients in period products and
33
discusses the risks those ingredients create for menstruators' health.
Subpart C discusses the unique structure of the vagina and how it relates
34
to the chemicals found in period products. In order to understand the
importance of disclosing the ingredients in period products, it is critical

york-first-state-nation-require-disclosure ("Requiring the disclosure of ingredients in menstrual
products will allow women and girls to make more informed decisions about the products they
use.") [hereinafter On Day of the Girl].
25. See infra Part I.
26.
27.

See infra Part II.
See infra Part III.

28. See infra Part III.C.
29. See infra Part IV.
30. See infra Part V.
31. See infra Part II.
32. See infra Part II.A.
33. See infra Part II.B.
34. See infra Part IIC.
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to know the health risks menstruators face from using these products
containing undisclosed ingredients. 5
A.

What Are Menstrual Products?

Menstrual products are products that are used by menstruators once
a month during menstruation. 36 These products generally include tampons, menstrual pads, menstrual cups, menstrual discs, and period
panties.3 Additionally, there is a separate category of hygiene products
branded toward women to allegedly help maintain vaginal cleanliness. 38
These products include feminine washes, 39 feminine wipes, 40 feminine
deodorants, 41 and vaginal douches."
These two categories of products are regulated differently under
current federal law.4 3 Under the Federal Food, Drug, and Cosmetic Act,
the former category of products are regulated as medical devices, and the
latter category of products are regulated as cosmetics." However, both
35. See On Day of the Girl, supra note 24.
36.

The Ultimate Guide to Feminine Hygiene, supra note 3.

37. Period Products: The Good,

the Bad,

and the

Ugly, UT HEALTH AUSTIN,

https://uthealthaustin.org/blog/period-products (last visited Aug. 1, 2021).

38. SCRANTON, supra note 2, at 8. The products in this category are not necessary for women
to use in order to maintain vaginal hygiene and cleanliness. Id. Many women use these products
because they do not understand that the vagina is self-cleaning and "normal secretions are a natural

self-cleaning process of the vaginal area." Barbra Hansen Cottrell, Vaginal Douching, 32 J.
OBSTETRIC, GYNECOLOGIC, & NEONATAL NURSING 12, 17 (2003). See Amanda Jenkins & Kieran
O'Doherty, The Clean Vagina, the Healthy Vagina, and the Dirty Vagina: Exploring Women's
Portrayalsin Relation to Vaginal Cleansing Product Use, FEMINISM & PSYCH., Aug. 25, 2020, at 2-

5, for further discussion about the reason women choose to use these hygiene products although
they are not necessary to maintain vaginal cleanliness.
39.

SCRANTON, supra note 2, at 14. Products like these are not recommended to maintain

routine vaginal hygiene. Cottrell, supra note 38, at 16.
40. SCRANTON, supra note 2, at 12. vaginal wipes are not recommended to be used on the
vagina but, if they are, they should be unscented. Cottrell, supra note 38, at 16 (explaining that
unscented wet wipes, if used, should be used once and then immediately discarded).
41. SCRANTON, supra note 2, at 16. Feminine deodorants include sprays, powders, and
suppositories. Id. These products are well known for their associated health risks. Id.
42. Id. at 15. Although regulated as cosmetics, vaginal douches have created health problems
for women. Cottrell, supra note 38, at 12-13. Some of these health complications include bacterial
vaginosis, increased risk of HIV and chlamydia, pelvic inflammatory disease, reduced fertility, and
ectopic pregnancy. Id. at 13.
43. SCRANTON, supra note 2, at 8.
44.

Id. Under federal law, cosmetics must be "free of poisonous or deleterious substances that

might harm users under conditions of normal use." Id. Regarding safety testing for cosmetics, the
FDA determined:
Companies and individuals who manufacture or market cosmetics have a legal
responsibility to ensure the safety of their products. Neither the law nor FDA regulations
require specific tests to demonstrate the safety of individual products or ingredients. The
law also does not require cosmetic companies to share their safety information with the
FDA.

Published by Scholarly Commons at Hofstra Law, 2021

5

Hofstra Law Review, Vol. 49, Iss. 4 [2021], Art. 6
HOFSTRA L AW R EVIEW

1056

[Vol. 49:105 1

45
categories of products pose dangerous risks to women's health. This
Note addresses the former category of menstrual products that are
regulated as medical devices."

1. Tampons and Menstrual Pads
The most commonly used and well-known period products are
48
tampons 47 and menstrual pads. Tampons are inserted directly into the
49
vagina to absorb menstrual blood and prevent leakage. The FDA
recommends that tampons should be changed every four to eight hours
50
to reduce the risks associated with tampon use. Under federal law,
tampons are broken down into two categories: unscented menstrual
tampons, 5 ' and scented or scented deodorized menstrual tampons. 52
Unscented tampons and scented or scented deodorized tampons are
53
classified as Class II medical devices. This classification is significant
because it determines how the FDA regulates the safety testing and
54
disclosure of ingredients in period products.

Id. As a result, in 2019, the United States House of Representatives ("U.S. House") proposed a bill
to amend the Federal Food, Drug, and Cosmetic Act to make the regulation of cosmetics safer. See
Safe Cosmetics and Personal Care Products Act of 2019, H.R. 4296, 116th Cong. (2019).
45. See SCRANTON, supra note 2, at 20.
46. See infra Part II.A.1-2.
47. See SCRANTON, supra note 2, at 6 (analyzing a study that found between fifty to eighty
percent of women use tampons).
48. See id. (finding between sixty-two and seventy-three percent of women use menstrual
pads during their period).
49. How Do I Use Tampons, Pads, Period Underwear, and Menstrual Cups?, PLANNED
https://www.plannedparenthood.org/lear/health-and-wellness/menstruation/howPARENTHOOD,

do-i-use-tampons-pads-and-menstrual-cups (last visited Aug. 1, 2021) ("[T]ampons are little plugs
made of cotton that fit inside your vagina and soak up menstrual blood.").
50.

See The Facts on Tampons-and How to Use Them Safely, U.S. FOOD & DRUG ADMIN.,

(last
https://www.fda.gov/consumers/consumer-updates/facts-tampons-and-how-use-them-safely
visited Aug. 1, 2021).
51. 21 C.F.R. § 884.5470 (2020). Unscented tampons are defined as a medical device that is
"a plug made of cellulosic or synthetic material that is inserted into the vagina and used to absorb
menstrual or other vaginal discharge. This generic type of device does not include menstrual
tampons treated with scent (i.e., fragrance materials) or those with added antimicrobial agents or
other drugs." Id.
52. Id. § 884.5460. Scented or scented deodorized menstrual tampons are defined as "a device
that is a plug made of cellulosic or synthetic material that is inserted into the vagina and used to
absorb menstrual or other vaginal discharge. It has scent (i.e., fragrance materials) added for
aesthetic purposes (scented menstrual tampon) or for deodorizing purposes (scented deodorized
menstrual tampon)." Id.
53. Id.; id. § 884.5470.
54. See SCRANTON, supra note 2, at 8. For a further discussion of the importance of medical
device classification see infra Part III.A.1.
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Separately, menstrual pads are often made of absorbent fibers that
have an adhesive to stick to underwear to absorb a menstruator's flow.55
Similar to tampons, under federal law, pads are broken down into two
categories: unscented menstrual pads 56 and scented or scented deodorized menstrual pads. 57 Pursuant to federal law, unscented pads are Class
I medical devices. 58 On the other hand, depending on the material out of
which the pad is made, scented or scented deodorized menstrual pads are
classified as a Class I or Class II medical device. 59
2. Menstrual Cups, Menstrual Discs, and Period Panties
Recently, in response to concerns associated with traditional period
products, like tampons and menstrual pads," new period products have
emerged with growing popularity. 61 These products include menstrual
cups,62 menstrual discs, 63 and period panties. " Unlike other period
55.

See PeriodProducts: The Good, the Bad, and the Ugly, supra note 37.

56. 21 C.F.R. § 884.5435 (2020). Unscented menstrual pads are defined as:
[A] device that is a pad made of cellulosic or synthetic material which is used to absorb
menstrual or other vaginal discharge. This generic type of device includes sterile
unscented menstrual pads used for medically indicated conditions but does not include
menstrual pads treated with scent (i.e., fragrance materials) or those with added
antimicrobial agents or other drugs.
Id.
57. Id. § 884.5425. Scented or scented deodorized menstrual pads are defined as "a device
that is a pad made of cellulosic or synthetic material which is used to absorb menstrual or other
vaginal discharge. It has scent (i.e., fragrance materials) added for aesthetic purposes (scented
menstrual pad) or for deodorizing purposes (scented deodorized menstrual pad)." Id.

58. Id. § 884.5435.
59. See id. § 884.5425. Menstrual pads made of "common cellulosic and synthetic material
with an established safety profile" are classified as Class I medical devices. Id. Scented or scented
deodorized menstrual pads not made of these materials are classified as Class II medical devices. Id.
Unscented pads are classified as Class I medical devices. Id. § 884.5435.
60. PeriodProducts: The Good, the Bad, and the Ugly, supra note 37. There are health and
environmental concerns associated with traditional period products. See id. See Alejandra Borunda,
How Tampons and Pads Became So Unsustainable, NAT'L GEOGRAPHIC (Sept.

16, 2019),

https://www.nationalgeographic.com/environment/2019/09/how-tampons-pads-becameunsustainable-story-of-plastic, for a further discussion of the impact of period products on the
environment.

61. See Melissa Kang, Menstrual Cups vs Tampons - Here's How They Compare, THE
CONVERSATION (July 22, 2019, 3:59 PM), https://theconversation.com/menstrual-cups-vs-tamponsheres-how-they-compare-120499.
62. PeriodProducts: The Good, the Bad, and the Ugly, supra note 37.
63. Id. Menstrual discs are similar to menstrual cups because they are inserted into the vagina
to collect menstrual fluid. Menstrual Discs vs. Period Cups, THE FORNIX (Jan. 27, 2020),
https://flexfits.com/blogs/thefixx/menstrual-discs-vs-menstrual-cups-what-s-the-difference.
However, unlike menstrual cups, menstrual discs are single use, sit in the vaginal fornix, and can be
worn during sexual intercourse. See id.
64. Rose Eveleth, The Science Behind Period Underwear, RACKED (Jan. 5, 2016, 10:00 AM),
https://www.racked.com/2016/1/5/10708976/period-underwear-technology.
Period panties are
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products, menstrual discs and period panties are not currently addressed
under federal law. 65
However, the Federal Food, Drug, and Cosmetic Act recognizes
menstrual cups as a category of period products. 66 Under federal law,
menstrual cups are defined as "a receptacle placed in the vagina to
collect menstrual flow." 67 Menstrual cups are typically made out of
"medical-grade silicone, rubber, latex, or elastomer and can last up to
[ten] years." 68 Federal law classifies menstrual cups as a Class II medical
device. 69
B.

Why Are PeriodProductsDangerous to Menstruators'Health?

Generally, the FDA has deemed menstrual products safe for women
to use. 70 According to one of the leading studies on the ingredients in
period products, "[n]either the Food and Drug Administration (FDA) nor
the Environmental Protection Agency (EPA) has direct authority to
7
monitor or require safety testing for feminine care products." 1 This
means, in the United States, toxic ingredients in period products are
72
completely unregulated by the government.
Research regarding the effect of menstrual products on reproductive
7
health did not begin in the United States until the 1990s. 1 In 1997, the
United States House of Representatives ("U.S. House") first conducted
an investigation into the undisclosed ingredients found in period
underwear that can be worn during a woman's period to absorb menstrual fluid. See Underwear
That Absorbs Your Period, THINX, https://www.shethinx.com/pages/thinx-it-works (last visited
Aug. 1, 2021). Period panties have been around since World War I. Carina Hsieh, The 10 Best
Period

Panties,

COSMOPOLITAN

(May

5,

2020),

https://www.cosmopolitan.com/sex-

love/a20964907/period-panties. Yet, despite their growth in popularity, there is not much
information readily available concerning the kind of material out of which the underwear is made.
See Eveleth, supra (stating that there is a lack of information on the materials used to make period
panties).
65. See 21 C.F.R. § 884.5400 (2020); 21 C.F.R. § 884.5425 (2020); 21 C.F.R. § 884.5435
(2020); 21 C.F.R. § 884.5460 (2020); 21 C.F.R. § 884.5470 (2020) (failing to recognize menstrual
discs and period panties).
66. See 21 C.F.R. § 884.5400 (2020).
67. Id.
68. Anna Maria van Eijk et al., Menstrual Cup Use, Leakage, Acceptability, Safety and
Availability: A Systematic Review and Meta-Analysis, 4 LANCET PUB. HEALTH e376, e377 (2019).
Single-use menstrual cups also exist, but they are less common. See id.
69. 21 C.F.R. § 884.5400.
70. Raymond, supranote 18 (discussing the procedures the FDA followed to test the safety of
tampons).
71. SCRANTON, supra note 2, at 8.
72. See id.
73. See Nicole Wendee, A Question in Women's Health: Chemicals in Feminine Hygiene
Products and Personal Lubricants, 122 ENv'T HEALTH PERSP. A70, A71 (2014) (stating that the

National Institutes of Health did not start a program for vaginal research until 1992).
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products. 74 Since then, the U.S. House has updated its research, and
independent medical studies have further investigated the undisclosed
dangerous ingredients in period products. 75 Yet, there is still inadequate
information about the effects of undisclosed ingredients, and risks, of
period products. 76
1. Studies Reveal the Ingredients in Menstrual Products
Medical studies have exposed the toxic ingredients in menstrual
products."7 These studies found alarming chemicals in tampons and
menstrual pads. 78 However, despite these studies, the extent of the
dangerous, undisclosed ingredients in period products is still an
under-researched topic. 79
Tampons are primarily composed of cotton and rayon, 80 that go
through a chlorine-bleaching process.81 The toxic chemicals found in
tampons likely stem from the bleaching process, which leaves behind
traces of dioxin. 82 Cotton and rayon "can be contaminated with highly
toxic dioxins when bleached with chlorine compounds, as well as
pesticides from non-organic cotton." 83

74. See Tampon Safety and Research Act of 1997, H.R. 2900, 105th Cong. (1997).
75.

See SCRANTON, supra note 2, at 20; Wendee, supra note 73, at A72.

76. Robin Danielson Feminine Hygiene Product Safety Act of 2017, H.R. 2379, 115th Cong.
(2017); SCRANTON, supra note 2, at 5.
77. SCRANTON, supra note 2, at 9-10; H.R. 2900; What's in Your Tampon? 2018 Tampon

Testing Results, supra note 20 (analyzing studies that revealed the ingredients in menstrual
products). Although all people that use period products are susceptible to the health risks associated
with these products, Hispanic and Black women have experienced more health issues from using
period products. See Wendee, supra note 73, at A72. See SCRANTON, supra note 2, at 7, for a

further discussion of the relationship between race and reproductive health issues.
78.

See SCRANTON, supra note 2, at 9-11.

79. See, e.g., id. at 3.
80.

See So,

What's Really in Tampax Tampons?, TAMPAX, https://tampax.com/en-us/tampon-

truths/what-tampons-are-made-of(last visited Aug. 1, 2021); SCRANTON, supra note 2, at 9. Rayon
is a synthetic fiber that can "cause the production of large quantities of toxins absorbed by the
vaginal mucosa." Wendee, supra note 73, at A73. But see The Facts on Tampons - and How to Use

Them Safely, supra note 50 ("The absorbent fibers used in FDA-cleared tampons sold today are
made with a bleaching process that is free from elemental chlorine, which also prevents products
from having dangerous levels of dioxin.").
81. See RUNE LEITHE, WHY THE TOXIC TAMPON ISSUE ISN'T GOING AWAY 3 (2018),
https://www.environmentalpaper.org/wp-content/uploads/2018/03/RL_7mars_2018-1 .pdf.
82. Id.; Tampon Safety and Research Act of 1999, H.R. 890, 106th Cong. § 2(4) (1999).
83. SCRANTON, supra note 2. The FDA reported that menstrual product manufacturers no
longer use chlorine when bleaching tampons. The Facts on Tampons - and How to Use Them
Safely, supra note 50. However, dioxins are still found in tampons. See Robin Danielson, Feminine
Hygiene Product Safety Act of 2017, H.R. 2379, 115th Cong. § 2(3) (2017).
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Furthermore, furans and pesticide residues have also been found in
tampons.8 4 Similar to dioxin, furans are a chemical that comes from the
process of bleaching tampons. 85 Moreover, pesticide residues result from
traditionally grown cotton. 86 The dioxins, furans, and pesticides found in
87
tampons are undisclosed by period product manufacturers.
Similar to tampons, the material in menstrual pads go through a
88
bleaching process which leaves behind traces of dioxins and furans.
89
Studies found traces of pesticides in cotton menstrual pads as well.
Like tampons, these chemicals found in menstrual pads are unregulated
by the FDA and remain undisclosed to the consumer.90
Additionally, period products with fragrances create a higher risk of
9
containing undisclosed, dangerous chemicals. 1 Scented tampons have
added fragrances, and it is unclear what ingredients are in these
fragrances. 92 Similarly, while testing menstrual pads that were not
labeled as scented, a study found traces of fragrances that pose health
93
risks to women which were undisclosed to the consumer. Due to the
lack of transparency of ingredients in period products, experts suggest
94
that women use 100% organic cotton tampons.

84. SCRANTON, supra note 2, at 20.
85. Id.
86. Id.
87. Id.
88. Id. at 11.
89. Id.
90. Id.
91. Id. at 10-11 ("Unfortunately, a 'fragrance' is a mixture of ingredients that can include any
of over 3,000 different chemicals; and the components of any one fragrance are usually kept secret
by manufacturers. According to a master list of fragrance chemicals made available by the
International Fragrance Association, fragrances can include chemicals which are carcinogens,
irritants, allergens, and potential endocrine disruptors.").
92. See id. Beginning in Spring 2021, Tampax no longer manufactures tampons with
fragrance. See id.
93. See SCRANTON, supra note 2, at 11.
94. See Wendee, supra note 73, at A73. Recently, recognizing the risks associated with
popular tampon brands, new companies have emerged that offer 100% cotton tampons. See Andrea
Yip, Rise of the 100% Organic Tampon, RED DOT PROJECT (Sept. 8, 2019),
But
https://www.reddotprojecttoronto.org/single-post/2019/08/26/Rise-of-the-100-Organic-Tampon.
see Caroline Praderio, Organic Tampons Aren't Worth Your Money - Here's Why, INSIDER (Oct. 2,
7 9
2
2017, 2:00 PM), https://www.insider.com/are-organic-tampons-safer-better- 01 - (explaining that
organic cotton tampons carry the same risk of toxic shock syndrome ("TSS") as other tampons and,
therefore, are not always safer).
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2. Health Risks from Menstrual Products
The chemicals discovered in menstrual products create many health
risks for the people who use them. 95 Numerous studies revealed dioxin
as a dangerous chemical commonly found in period products. 96 Dioxin is
a "probable human carcinogen."9 7 However, the FDA is not concerned
with dioxin levels in period products because they consider the levels of
dioxin safe. 98 The FDA makes recommendations about the dioxin levels
in menstrual products, but these recommendations are not mandatory for
menstrual product manufacturers to follow. 99
Moreover, the U.S. House reported that "[i]nternal documents of
the Food and Drug Administration suggest the agency has not
adequately investigated the danger of dioxin in tampons."100 In assessing
the safety of dioxin levels, the FDA relied on data from "paper mill
officials" rather than studies that directly test the effect of dioxins in
period products on the unique composition of the vagina. 101
Additionally, the FDA leaves period product companies to regulate the
level of dioxins in their own products.102 These levels are not made
available to the public. 103
Despite the FDA's assessment of dioxins, private studies, as well as
government research, revealed that dioxins can have an adverse effect on
reproductive health in the aggregate.104 The U.S. House reported, "[t]he
effects of dioxin from various sources are cumulative and can be meas-

95. See id. at 20; Tampon Safety and Research Act of 1997, H.R 2900, 105th Cong.
(1997) (revealing the negative health effects that women experience from using
menstrual products with hazardous ingredients).
96. See SCRANTON, supra note 2, at 20; Michael J. Devito & Arnold Schecter, Exposure
Assessment to Dioxins from the Use of Tampons and Diapers, 110 ENV'T HEALTH PERSP. 23, 27
(2002); Robin Danielson Feminine Hygiene Product Safety Act of 2017, H.R. 2379, 115th Cong.
§ 2(3) (2017).
97. H.R. 2379 § 2(3).
98. Wendee, supra note 73, at A73 ("[T]he U.S. Food and Drug Administration (FDA)
describes the risk of adverse effects from dioxins in tampons as 'negligible."').

§ 486C(a)(1)(A)

99.

SCRANTON, supra note 2 ("FDA guidance for the marketing of tampons recommends that

tampons be ... 'free of 2,3,7,8-tetrachlorodibenzo-p-dioxin(TCDD)/2,3,7,8-tetrachlorofuran
(TCDF) and any pesticide and herbicide residues."').
100. Tampon Safety and Research Act of 1999, H.R. 890, 106th Cong. § 2(6) (1999).
101.

See JAMIE M. KOHEN, THE HISTORY OF THE REGULATION OF MENSTRUAL TAMPONS 28

(2001), https://dash.harvard.edu/bitstream/handle/1/8852185/Kohen.pdf?sequence=1&isAllowed=y.
See Marc Smolonsky & Phillip J. Wakelyn, Dioxin in Single-Use Diapers and Tampons, 67
MOTHERING 44 (1993), for a further discussion of the role paper companies play in dioxin testing.
102. H.R. 890 § 2(7).
103. Robin Danielson Feminine Hygiene Product Safety Act of 2017, H.R. 2379, 115th Cong.
§ 2(5) (2017).
104. See Wendee, supra note 73, at A73; Tampon Safety and Research Act of 1997, H.R.
2900, 105th Cong. § 2(3) (1997).
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"

105
A woman's reproductive
ured twenty to thirty years after exposure."
life lasts approximately sixty years, meaning dioxin levels are
cumulating throughout the many years a woman is using period
products.106
Due to the undisclosed chemicals, period products have caused a
multitude of health issues for menstruators. 107 Dioxins and furans have
been linked to cancer, endocrine disruption, 108 and reproductive
toxicity. 109 Similarly, pesticide residues have been linked to cancer,
0
endocrine disruptions, and acute toxicity." Moreover, the chemicals
found in period products can interfere with "estrogen signaling."
Tampons are also known to cause vaginal ulcers." 2
for
problems
health
cause
pads
menstrual
Similarly,
3
menstruators. " One common problem menstruators experience from
using menstrual pads is contact dermatitis.1 1 4 Menstrual pads can also
1 5
cause irritation, itching, burning, and allergic rashes on the vulva.

105. H.R. 2900 @ 2(3).
106. H.R. 890 § 2(5).
107. See, e.g., SCRANTON, supra note 2, at 20.
108. Id. Endocrine disruption can interfere with reproduction, increase the risk of cancer, and
affect the immune and nervous system function. Endocrine Disruption,ENv'T PROT. AGENCY (Feb.
22, 2017), https://www.epa.gov/endocrine-disruption/what-endocrine-disruption.
109. SCRANTON, supra note 2, at 20. Reproductive toxicity is "any effect of chemicals that
would interfere with reproductive ability or capability, with subsequent effects on lactation and the
development of offspring .... " Efstathios Nikolaidis, Relevance of Animal Testing Sensitivity of
End Points in Reproductive and Developmental Toxicity, in REPRODUCTIVE AND DEVELOPMENTAL
TOxICOLOGY 111 (Ramesh C. Gupta ed., 2011).
110. SCRANTON, supranote 2, at 20.
111. Wendee, supra note 73, at A72. Estrogen signaling "refers to all proteins of estrogen
function and related regulatory proteins." Estrogen Signaling Pathway, CREATIVE DIAGNOSTICS,

https://www.creative-diagnostics.com/estrogen-signaling2
2
pathway.htm#:~:text=The%20estrogen%20signaling%20pathway%20refers,function% 0and% 0re
ated%20regulatory%20proteins.&text=Estrogen%20works%20mainly%20by%20binding,cytoplas
m%20to%20play%20its%20role (last visited Aug. 1, 2021). Estrogen signaling is important because
it can "regulate function" in cancers including breast cancer and leukemia. See Simon P. Langdon,

Estrogen Receptor Signaling in Cancer, MDPI (Sept. 24, 2020), https://www.mdpi.com/20726694/12/10/2744/htm.
112.

Weissberg & Dodson, supranote 1, at 1431. But see Scientist Sees a Connection Between

Endometriosis and Tampon Use, Orgasm, YALE MED., Autumn 2002, at 15 (discussing one study
that found that using tampons can protect women against endometriosis).
113.

See SCRANTON, supra note 2, at 11; Wendee, supra note 73, at A73.

114. Wendee, supra note 73, at A73; Letter from Women's Voices for the Earth et al. to
Members of Congress (Aug. 5, 2020) (on file with author) ("Acrylates and methacrylates are also
commonly included in menstrual pads. The disclosure of specific acrylates and methacrylates used
in pads is lacking, but there are several published case studies of patients with diagnosed contact
dermatitis from exposure to acrylates from the use of menstrual products and incontinence pads.").
115.

SCRANTON, supra note 2, at 11.
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Additionally, period products have been linked to vaginal yeast
infections and bacterial vaginosis.116 As a result, many women seek
over-the-counter treatment to deal with the irritation they experience." 7
However, the ingredients in the over-the-counter treatments, which are
often undisclosed under federal law, can exacerbate the problems

women experience." 8
In 2018, a study tested tampons from popular brands to investigate
whether they contained undisclosed chemicals." 9 This study revealed
that "there may be ingredients ... in tampons leading to exposure to
chemicals of concern." 120 Although period products contain undisclosed
chemicals, due to the lack of research regarding the effects of chemicals
on the vagina, the severity of this concern is unclear.1 2 1 Nevertheless, it
is clear from medical studies that period products contain undisclosed
chemicals and other toxic ingredients that pose serious risks to the health
of people who use period products.1 22
C.

The Uniqueness of the Vagina and Why It Matters

The toxic ingredients in menstrual products create a magnified
health risk because of the area of the body in which these products are
used.1 23 Therefore, it is vitally important to consider the structure and
uniqueness of the vagina when discussing the impact of period products
on menstruators' health.1 24 Some period products, like tampons, menstrual cups, and menstrual discs, are inserted directly into the vagina.12 1
Other products, like menstrual pads and period panties, make direct
contact with the vulvar Skin.1 26
Both vaginal and vulvar tissue are "structurally different than the
skin of the rest of the body" and, therefore, are more sensitive to the

116. wendee, supranote 73, at A73.
117. Id.
118.

Id. (explaining that over-the-counter treatments can create "overgrowth of azole-resistant

yeast species" and anogenital dermatitis).
119.

What's in Your Tampon? 2018 Tampon Testing Results, supra note 20.

120. Id.
121. Id. Moreover, due to the lack of research, it is unclear whether menstrual cups, menstrual
discs, and period panties create medical concerns for menstruators' health. See How Do I Use
Tampons, Pads, PeriodUnderwear, and Menstrual Cups?, supra note 49.

122.

See supra Part IIB. 1-2.

123.

See SCRANTON, supranote 2, at 4.

124. wendee, supra note 73, at A72 (discussing research which showed that the structure of
the vagina affects the rate at which toxic chemicals from menstrual products are absorbed into the
body).
125. See Kang, supra note 61 (explaining that both tampons and menstrual cups are used by
inserting them into the vagina).
126. See SCRANTON, supra note 2, at 11.
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127
toxic chemicals found in period products. Vaginal and vulvar tissue
128
are covered in mucous membranes. Unlike the skin, "[d]rugs absorbed
from the vagina does [sic] not undergo first-pass metabolism because
blood leaving the vagina enters the peripheral circulation via a rich
12 9
venous plexus, which empties primarily into the internal iliac veins."
Moreover, the vagina and the vulva are "capable of secreting and
0
absorbing fluids at a higher rate than skin."" The large number of blood
vessels in the vagina allow absorption to occur more quickly than regular skin."' These blood vessels allow for "direct transfer of chemicals in
to the circulatory system." 2 Therefore, the chemicals discovered in
period products are absorbed at a higher rate than if they came into
contact with the skin.1 33 Yet, the FDA considers the chemicals in period
products safe based only on data from products tested on skin, which is
4
less absorbent than the mucous membrane."

III.

THE UNREGULATED REGULATION OF THE INGREDIENTS IN
MENSTRUAL PRODUCTS

This Part discusses the inadequate legislation governing the
disclosure and labeling requirements for menstrual product ingredients
in the United States.135 Subpart A will discuss the Federal Food, Drug,
and Cosmetic Act and the Medical Device Amendments that set forth
136
the disclosure requirements for the ingredients in menstrual products.
Subsequently, Subpart B will discuss the FDA's authority over requiring
37
Subpart C
manufacturers to make disclosures for menstrual products.
will discuss state action taken to require period product manufacturers to
138
disclose the ingredients in the period products sold in their states. This
Subpart entails the New York and California Menstrual Products Right
to Know Acts, which set forth the period product ingredient disclosure

127. Id. at 4.
128. Id.
129. Alamdar Hussain & Fakhrul Ahsan, The Vagina as a Route for Systemic Drug Delivery,
103 J. CONTROLLED RELEASE 301, 302 (2005).

130.
131.
through
Hussain
132.
133.

Wendee, supra note 73, at A72.
See id. Due to its high absorption rate, medical studies have tested administering drugs
the vagina rather than orally or on the skin to get the drugs into the bloodstream faster.
& Ahsan, supra note 129, at 302.
SCRANTON, supranote 2, at 4.
See Wendee, supra note 73, at A72.

134.

See id.; SCRANTON, supranote 2, at 5.

135.
136.
137.
138.

See infra Part III.
See infra Part III.A.
See infra Part III.B.
See infra Part III.C.
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requirements in New York and California.13 9 Finally, Subpart D will
discuss the proposed bill in the U.S. House attempting to amend the
Federal Food, Drug, and Cosmetic Act. 140 This Subpart also explains
why the proposed bill, also known as the Menstrual Products Right to
Know Act, is inadequate in ensuring all people who menstruate know
the ingredients in period products.141
A.

The FederalFood, Drug, and Cosmetic Act

The FDA regulates menstrual products through the Federal Food,
Drug, and Cosmetic Act. 4 2 The Federal Food, Drug, and Cosmetic Act
was originally passed in 1938 to allow consumers to know important
information about the products they use, including the ingredients in
products.14 3 More importantly, this law gave the FDA the "authority to
regulate medical devices and cosmetics, and to establish standards for
foods." 1"4 The three main categories regulated under this federal legislation include food,14 5 drugs and devices,1 4 6 and cosmetics.14 1
Over time, with developments in research and ongoing discoveries,
the Federal Food, Drug, and Cosmetic Act has been amended multiple
times. 148 Most significantly, in 1976, the Medical Device Amend-

139.
140.
141.
142.

See infra Part III.C.
See infra Part III.D.
See infra Part III.D.
21 U.S.C. § 301 et seq. (2018). The Federal Food, Drug, and Cosmetic Act was enacted in

the early twentieth century. See 80 Years of the FederalFood, Drug, and Cosmetic Act, U.S. FOOD

& DRUG ADMIN. (July 11, 2018), https://www.fda.gov/about-fda/virtual-exhibits-fda-history/80years-federal-food-drug-and-cosmetic-act.
143.

See 80 Years of the FederalFood, Drug, and Cosmetic Act, supra note 142.

144. Id. ("Drugs and devices were required to provide adequate directions for use; falsely
labeled uses were misbranded; and there was no longer a need to establish intent to defraud to prove
misbranding. In addition, it became illegal to market drugs or devices that inherently endangered
health, and all new drugs had to be proven safe for their labeled use before they could be
marketed."). The Federal Food, Drug, and Cosmetic Act was largely a consumer protection law. See
id.
145. See 21 U.S.C. §§ 341-350 (2018). The Federal Food, Drug, and Cosmetic Act regulates,
inter alia, adulterated food, misbranded food, nutrition labeling, dietary supplements, food
additives, bottled drinking water, and infant formulas. Id. §§ 342-350.
146. See id. §§ 351-360 (2018). The drugs and devices section of the Federal Food, Drug, and
Cosmetic Act covers a wide range of drugs and devices. See id. The regulated areas include
adulterated drugs and devices, misbranded drugs and devices, new drugs, clinical trials, animal
drugs, medical gases, as well as many others. Id.
147. See id. §§ 361-364 (2018). The relevant sections of the Federal Food, Drug, and Cosmetic
Act regulate adulterated cosmetics, misbranded cosmetics, and other cosmetic regulations. See id.
148. See e.g., Nutrition Labeling and Education Act of 1990, Pub. L. No. 101-535, § 1(a), 104
Stat. 2353 (2018) (codified as amended at 21 U.S.C. §§ 337, 343, 343(i), 345, 371(e)); Food Quality
Protection Act of 1966, Pub. L. No. 104-170, § 401, 110 Stat. 1513 (2018) (codified as amended at
7 U.S.C. § 321 et seq.); Securing Opioids and Unused Narcotics with Deliberate Disposal and

Published by Scholarly Commons at Hofstra Law, 2021

15

Hofstra Law Review, Vol. 49, Iss. 4 [2021], Art. 6

HOFSTRA LA W REVIEW

1066

[Vol. 49:1051

ments 49 were adopted to amend the Federal Food, Drug, and Cosmetic
Act. 50 In 1980, the Medical Device Amendments were further amended
15
to include menstrual products as medical devices." Therefore, under
current federal regulations, period products are classified as medical
devices. 5 2 As a result of this classification, companies are not required
to disclose the dangerous ingredients in menstrual products that create
serious health risks. 5 3
1. Medical Device Amendments
The Medical Device Amendments of the Federal Food, Drug, and
Cosmetic Act 154 govern the current disclosure requirements of the
ingredients in menstrual products."5 Period products are classified as
medical devices because they "are intended to affect the function of the
body." 156 Medical devices are broken down into three classes depending
7
on the risk the device carries. 5 These classifications include Class I

Packaging Act of 2018, Pub. L. No. 115-271,
21 U.S.C. § 355 et seq.).
149. 21 U.S.C. § 360 et seq. (2018).
150.

§ 3031,

132 Stat. 3940 (2018) (codified as amended

See INST. OF MED. OF THE NAT'L ACADS., PUBLIC HEALTH EFFECTIVENESS OF THE FDA

510(K) CLEARANCE PROCESS 3 (Theresa wizemann ed., 2011).
151.

See Tina Beaudoin, Are Your Tampons a Medical Device?, EMERSON ECOLOGICS,

https://edu.emersonecologics.com/2017/04/1 1/are-your-tampons-a-medical2
2
device/#:~:text=Yes%2C%20your%20tampons%20are%20considered,government% 0and% 0FD
A%20since%201980 (last visited Aug. 1, 2021).
152. SCRANTON, supra note 2, at 8.
153. See KOHEN, supranote 101, at 25.
154. 21 U.S.C. § 360 et seq. (2018).
155. See KOHEN, supra note 101, at 3. Medical devices are defined as:
[A]n instrument, apparatus, implement, machine, contrivance, implant, in
vitro reagent, or other similar or related article, including any component,
part, or accessory, which is(1) recognized in the official National Formulary, or the United States
Pharmacopeia, or any supplement to them,
(2) intended for use in the diagnosis of disease or other conditions, or in the
cure, mitigation, treatment, or prevention of disease, in man or other animals,
or

(3) intended to affect the structure or any function of the body of man or other
animals, and which does not achieve its primary intended purposes through
chemical action within or on the body of man or other animals and which is
not dependent upon being metabolized for the achievement of its primary
intended purposes.
21 U.S.C. § 321(h) (2018).
156. Andrea Donsky, Why Are Tampons Classifiedas Medical Devices?, NATURALLY SAVVY,
https://naturallysavvy.com/care/why-are-tampons-classified-as-medical-devices (last visited Aug. 1,
2021).
157.

See What's the Difference Between the FDA Medical Device Classes?, BMP MED.,

https://www.bmpmedical.com/blog/whats-difference-fda-medical-device-classes-
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Medical Devices,158 Class II Medical Devices,1 59 and Class III Medical
Devices.1 60
Under current federal law, unscented menstrual pads are Class I
medical devices 16 1 because the FDA considers these menstrual pads
"low risk medical devices."1 62 Moreover, all tampons and menstrual
cups are Class II medical devices1 63 because they are higher risk medical
devices than unscented menstrual pads.'6' On the other hand, depending
on the risk of the material they are composed of, scented or scented
deodorized menstrual pads are classified as either Class I or Class II
medical devices.1 65
Under this classification, period product manufacturers are
"requiredto submit to [sic] FDA a detailed risk assessment of the device
components, the design, and the test results."166 The submissions made
2/#:~:text=A%20Class%20I%20medical%20device%20are%20those%20devices%20that%20have,
exempt%20from%20the%20regulatory%20process (last visited Aug. 1, 2021).
158. See id. ("Class I medical device[s] are those devices that have a low to moderate risk to
the patient and/or user. Today, [forty-seven percent] of medical devices fall under this category and
95% of these are exempt from the regulatory process. If a device falls into a generic category of
exempted Class I devices, a premarket notification application and FDA clearance is not required
before marketing the device in the U.S. However, the manufacturer is required to register their
establishment and list their generic product with FDA. Examples include enema kits, elastic
bandages, manual stethoscopes, and bedpans.").
159. See id. ("Class II medical devices are those devices that have a moderate to high risk to
the patient and/or user. 43% of medical devices fall under this category. Most medical devices are
considered Class II devices. Examples of Class II devices include powered wheelchairs and some
pregnancy test kits.").
160. See id. ("Class III medical devices are those devices that have a high risk to the patient
and/or user. These devices usually sustain or support life, are implanted, or present potential
unreasonable risk of illness or injury. They represent 10% of medical devices regulated by the FDA.
Examples of Class III devices include implantable pacemakers and breast implants.").
161. See supra Part II.Al.
162. Donsky, supra note 156.
163. See supra Part II.A.1-2.
164.

See What's the Difference Between the FDA Medical Device Classes?, supra note 157.

165.

See supra Part II.A.1.

166.

FDA

Regulation

of

Tampons

and

Pads,

FEMCARE

ANSWERS,

https://www.femcareanswers.com/safety/regulation (last visited Aug. 1, 2021) (describing the FDA
submission process to include a "[d]etailed description of the products including its composition;"
"[d]etailed risk assessments;" "[a]ssessments of human safety, such as irritation and allergy, in
accordance with internationally-recognized consensus standards;" "[c]onfirmation [sic] the
microbiological safety of tampons;" and "[e]valuation of the intended labeling to assure women
have access to the proper usage and safety information"). Under the Medical Device Amendments,
manufacturers must "submit to the FDA a pre-market approval ("PMA") application . .. before
making any change affecting the safety or effectiveness of the device." KOHEN, supra note 101, at 4

("Some of the changes which require a PMA supplement include: '1) new indication for use of the
device; 2) labeling changes; 3) the use of a different facility or establishment to manufacture,
process, or package the device; 4) changes in sterilization procedures; 5) changes in packaging.' If a
change 'does not affect the device's safety or effectiveness and the change is reported to FDA,' the
change does not require submission of a PMA supplement.").
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67
to the FDA are not available to the public.1 Moreover, the labeling
requirements for medical devices under the Federal Food, Drug, and
Cosmetic Act require that "the device labeling bear adequate warnings
against dangerous uses to health, or information necessary for the
protection of users." 168 Notably, there is no requirement that medical
16 9
devices be labeled with their ingredients.
As Class I and Class II medical devices, period products are
currently governed by the same requirements regulating a multitude of
products including, among other things, carbon monoxide gas analyz73
72
ers,1 70 ureteral stents,171 dental preformed crowns,1 and audiometers.
These types of medical devices, some of which are used externally on
the body, are significantly different from period products. 174 Period
products are used in a unique, sensitive part of the body 175 and,
therefore, should not be regulated the same as other medical devices that
pose a lesser health risk.1 76

B.

The CurrentDisclosureRequirements Under FederalLaw Are
Insufficient

Under current federal law, the FDA requires a multitude of product
manufacturers to disclose and label the ingredients found in their
products. 177 In order for the FDA to have the authority to require

167. See Robin Danielson Feminine Hygiene Product Safety Act of 2017, H.R. 2379, 115th
Cong. § 2(5) (2017).
168.

U.S. FOOD & DRUG ADMIN., LABELING: REGULATORY REQUIREMENTS FOR MEDICAL

DEVICES 1 (1997), https://www.fda.gov/files/medical%20devices/published/Labeling---RegulatoryRequirements-for-Medical-Devices-(FDA-89-4203).pdf.
169.

See KOHEN, supra note 101, at 25.

170. See 21 C.F.R. § 868.1430 (2020) ("A carbon monoxide gas analyzer is a device intended
to measure the concentration of carbon monoxide in a gas mixture to aid in determining the
patient's ventilatory status.").

171.

See id.

§ 876.4620

(defining a ureteral stent as a "tube-like implant device inserted into

the ureter to . . . allow the passage of urine").

172.

See id.

§ 872.3330.

A preformed crown is a temporary device "affixed temporarily to a

tooth after removal of, or breakage of, the natural crown." Id.

173. See id. § 874.1050. An audiometer is a device used to conduct diagnostic hearing tests. Id.
174. See e.g., 21 C.F.R § 892.1000 (2020) (describing a magnetic resonance diagnostic device
as a Class II medical device); id. § 888.5960 (stating that an orthopedic cast removal instrument is a
Class I medical device).
175. See supra Part II.C.
176.

See KOHEN, supra note 101, at 25.

177. See On Day of the Girl, supra note 24; Laura E. Derr, When Food Is Poison: The History,
Consequences, and Limitations of the Food Allergen Labeling and Consumer Protection Act of

2004, 61 FOOD & DRUG L.J. 65, 66 (2006) (explaining that ingredients are required to be disclosed
in food products); U.S. FOOD & DRUG ADMIN., COSMETIC LABELING GUIDE 5 (2020),
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manufacturers to label menstrual products with their ingredients, they
must have information "indicating that such labeling is necessary for the
safe and effective use of [the products]." 178 The FDA has not yet
exercised this authority over the ingredients in period products.17 9
The FDA first exercised this authority by requiring menstrual
product manufacturers to label tampons with a warning for toxic shock
syndrome ("TSS").' 80 Despite the fact that tampons have existed since
the early twentieth century,1 81 TSS was not discovered until 1980.182
TSS is a life-threatening illness, and one of its main causes is tampon
use.1 83 After recognizing the seriousness of TSS,184 the FDA required
companies to label tampons with a warning regarding the risk of TSS.1 85
The FDA wanted consumers to be informed of the possible risks
associated with tampon use and exercised their authority to require
tampons to be labeled with a TSS warning.1 86

https://www.fda.gov/media/88234/download
(describing the labeling requirements for the
ingredients in cosmetics).
178. See KOHEN, supra note 101, at 27.
179. See SCRANTON, supra note 2, at 8. This is likely due to the fact that the FDA "has avoided
requests for nonmaterial information or, warning-like statements for ingredients that cause only
mild or idiosyncratic responses." See Fred H. Degnan, Biotechnology and the Food Label: A Legal
Perspective, 55 FOOD & DRUG L.J. 301, 306 (2000). But see SCRANTON, supra note 2, at 8
(discussing the serious health risks created by the undisclosed ingredients in menstrual products).
180. See KOHEN, supra note 101, at 10. In fact, when the Center for Disease Control and
Prevention ("CDC") first discovered that tampons caused TSS, they suggested that women stop
using tampons altogether to avoid the risk of TSS. See id. at 6 (explaining the CDC "recommended
that women who wish to avoid the risk of menstrually associated TSS stop using tampons").
181. See id. at 2.
182.

See Thomas Koenig & Michael Rustad, His and Her Tort Reform: Gender Injustices in

Disguise, 70 WASH. L. REV. 1, 41 (1995) ("Toxic shock syndrome (TSS) was first identified in
1980 as an infection which largely affects menstruating women.").
183. See Amanda L. Wilkins et al., Toxic Shock Syndrome - the Seven Rs of Management and

Treatment, 74 J. INFECTION 5147, S147-48 (2017). The symptoms of TSS include, inter alia,
decreased kidney functions, liver impairment, and difficulty breathing. Toxic Shock Syndrome
(TSS),
JOHNS
HOPKINS
MED.,
https://www.hopkinsmedicine.org/health/conditions-anddiseases/toxic-shock-syndrometss#:-:text=Toxic%20shock%20syndrome%20(TSS)%20is,cause%20severe%20damage%20and%2
Oillness (last visited Aug. 1, 2021).
184. See KOHEN, supra note 101, at 10. When it was first discovered that TSS was linked to
tampon use, the FDA was not quick to address this problem. See id. at 5-12. After multiple studies
and pushback from tampon manufacturers, the FDA finally adopted a requirement for tampons to be
labeled with TSS warnings. See id.
185. See 21 C.F.R § 801.430 (2020). This requirement applies to unscented and scented or
scented deodorized tampons. See id. Furthermore, if companies choose to include the warning in an
insert inside of the tampon box, the company must also label the outside of the box with an alert.
See id. However, the FDA does not mandate where on the box the warning must be displayed. See
KOHEN, supra note 101, at 11.
186. See KOHEN, supra note 101, at 8.
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One of the main causes of TSS from tampon use is attributed to the
18 7
previously undisclosed absorbency levels of tampons. The higher the
absorbency level of the tampon, the more likely the tampon is to cause
TSS. 188 As a result, the FDA recognized the risk consumers faced by not
knowing the absorbency level of tampons and required manufacturers to
189
Furthermore, the FDA set
label them with their absorbency level.
forth testing methods that tampon manufacturers must follow when they
measure the absorbency levels of tampons. 190 Regarding TSS and
tampon absorbency levels, the FDA uncovered sufficient evidence to
91
require tampon manufacturers to label their products.
The FDA has not exercised this authority to require menstrual
product manufacturers to disclose the ingredients in period products
despite knowing the risks associated with the ingredients in these
products. 192 When the FDA first investigated the health risks associated
with period products, there was a lack of research revealing the
numerous health risks associated with menstrual products beyond the
193
Therefore, the FDA only
use of tampons and their link to TSS.
187. See id. at 16 ("[T]he relative risk of TSS generally increases as the absorbency of the
tampon increases and that without regard to the chemical composition of the tampon, for each gram
increase in absorbency, there is a significant increase in the risk of illness.").
188. See David Samadi, Toxic Shock Syndrome Is Most Common with Use of Super-Absorbent
Tampons; Here Are the Best Ways to Prevent It, N.Y. DAILY NEWS (June 24, 2015, 6:30 AM),
https://www.nydailynews.com/life-style/health/doctor-minimize-risk-toxic-shock-syndrome-article1.2268476 ("Toxic shock syndrome has most commonly been associated with the use of superabsorbent tampons, which can instigate bacterial growth due to prolonged use.").
189. See 21 C.F.R. § 801.430. The absorbency categories include light absorbency, regular
absorbency, super absorbency, super plus absorbency, and ultra absorbency. Id. These categories of
absorbency are measured in grams. See id. Similar to the approval process of a TSS warning, when
the FDA first discovered that higher absorbency tampons are more likely to cause TSS, they were
not quick to require absorbency disclosure. See KOHEN, supra note 101, at 13 (stating that at the
start, "[t]he FDA believed that the voluntary standards process was the most efficient and
economical method available for developing uniform absorbency testing and labeling"). Ultimately,
the FDA recognized the need for uniform absorbency level labeling standards. See id. at 13-24
("[T]he FDA decided to standardize the current terms, and to require that the word 'absorbency'
accompany the terms to alert consumers that the packaging has been changed.").
190. See 21 C.F.R. § 801.430(f). The FDA also provides an exception to the absorbency level
testing methods set forth. See id. Tampons that are dispensed from a vending machine are exempt
from the TSS and absorbency labeling requirements. See id. See id. § 801.430, for the current
complete user labeling requirements for tampons.
191. See KOHEN, supranote 101, at 16.
192. See id. at 27 ("[T]he FDA responded that in the absence of data showing an association
between any ingredient and any risk to health, nor any legal theory under which the FDA could
reside, the FDA lacked the authority to mandate ingredient labeling.").
193. See id. at 26-27 ("Ultimately, the FDA felt it did not have the authority to adopt ingredient
labeling requirements. 'None of the comments favoring ingredient labeling cited, discussed, or
submitted any data showing an association between any ingredient in any currently marketed
tampon and any risk to health, including allergic reaction, sensitivity, or irritation, and FDA is
unaware of any such data."').
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required companies to label tampons with a TSS warning and the
absorbency level. 194
However, in addition to TSS, studies have exposed other health
risks associated with menstrual products.195 Beginning in the 1990s,
research developed and revealed that there is a myriad of health risks
associated with multiple period products. 196 Yet, the FDA has not
changed the labeling requirements for menstrual products to reflect this
new research.197
Although the FDA does not require manufacturers to disclose the
ingredients in menstrual products, federal law allows companies to make
ingredient disclosures on a voluntary basis. 198 Today, some of the most
popular menstrual product brands are Tampax, U by Kotex, and
Playtex, 199 and only one of these brands discloses the ingredients in their
products. 200 Albeit, the voluntary list of ingredients disclosed only
includes a limited list of generalized ingredients. 201 As a result of the
need for ingredient disclosure, new companies have emerged that market
their brand on ingredient transparency. 202 However, these ingredient
194. See id. at 11.
195.

See supra Part II.B; SCRANTON, supra note 2, at 20 (stating that menstrual products are

linked to cancer, endocrine disruption, and reproductive toxicity).
196. See SCRANTON, supra note 2, at 20; Robin Danielson Feminine Hygiene Product Safety
Act of 2017, H.R. 2379, 115th Cong. (2017); Tampon Safety and Research Act of 1999, H.R. 890,
106th Cong. (1999); Tampon Safety and Research Act of 1997, H.R. 2900, 105th Cong. (1997).
197. See SCRANTON, supra note 2, at 8 (stating that as medical devices, menstrual products
"lack any government requirement to disclose ingredients to the consumer").

198.

See id.

199.

See Syden Abrenica, Periods Are Uncomfortable (We Know) but These

10 Tampons Are

Not, BYRDIE (Oct. 21, 2019), https://www.byrdie.com/best-tampons-4766540. All of these brands
were tested in a study conducted by the Women's Voices for the Earth, which found volatile organic
compounds in their tampons. What's in Your Tampon? 2018 Tampon Testing Results, supra note

20.
200.

See

Everything

You

Need

to

Know

About

Periods,

U

BY

KOTEX,

https://www.ubykotex.com/en-us/periods (last visited Aug. 1, 2021) (omitting the ingredients in
their products); Period 101, PLAYTEX, https://www.playtexplayon.com/period-faq/period-101 (last
visited Aug. 1, 2021) (stating no ingredients in their products).
201.

See So, What's Really in Tampax Tampons?, supra note 80 (describing tampons as

containing "rayon, cotton, polypropylene, polyethylene, polyester, glycerin, paraffin, ethoxylated
fatty acid esters, PEG-100 Stearate, [and] titanium dioxide").
202.

See, e.g., Alexander Abraham, How Organic Tampons Compare to Non-Organic, THE

HONEY POT, https://thehoneypot.co/blogs/latest/how-organic-tampons-compare-to-non-organic (last
visited Aug. 1, 2020). Regarding ingredient disclosure, this company stated:
We want to eliminate the infections, irritation, cramps, and more issues that can stem
from toxins in tampons. Our natural organic tampons are created with organic cotton,
grown without any pesticides or chemicals. All of our natural organic tampons are also
fragrance-free and are wrapped in a BPA-free plastic applicator. we also proudly list all
ingredients on the box. We believe everyone should have a healthy period and know
what they are putting in their body.
Id.
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disclosures are only voluntary because federal law does not require
menstrual product companies to disclose the ingredients in their
products. 2 03
In the past, the FDA recognized the risk people faced because
tampons were not labeled with a warning for TSS or absorbency levels
2 04
and required period product manufacturers to make these disclosures.
The undisclosed ingredients in all menstrual products create a risk for
205
The current FDA regulations
menstruators' health of equal gravity.
206
are created by tampons.
that
only address some of the health risks
However, unscented and scented or scented deodorized tampons are not
207
the only period products that pose a risk to menstruators' health.
Moreover, TSS is not the only health risk created by unscented and
20
scented or scented deodorized tampons.
Today, studies revealed sufficient evidence that proves that the
undisclosed ingredients in menstrual products pose more than "mild or
2 10
idiosyncratic"209 health risks for menstruators. Therefore, the FDA has
the necessary information indicating that such labeling is necessary for
211
In order to ensure
the safe and effective use of menstrual products.
that menstruators are aware of the health risks they face when using
period products with undisclosed ingredients, federal law must require
menstrual product companies to disclose the ingredients in their
22
products.

203. See SCRANTON, supra note 2, at 8. As early as the 1980s, the FDA has been aware that the
undisclosed ingredients in menstrual products create health risks for women. See KOHEN, supra
note 101, at 26 ("[A]n FDA scientist warned, 'It is critical to an adequate risk assessment that the
level of dioxins in tampons, sanitary pads, diapers, and other medical devices be measured."').
204. See KOHEN, supra note 101, at 5-24 (canvassing this history).
205. See SCRANTON, supra note 2, at 20.
206. See 21 C.F.R. § 801.430 (2020).
207. See SCRANTON, supra note 2, at 20 (stating that the undisclosed ingredients in tampons
and menstrual pads create health risks for women).
208. See id. (discussing the multitude of health risks women face from using period products
with undisclosed ingredients).
209. Degnan, supra note 179, at 306.
210. See SCRANTON, supra note 2, at 20; Robin Danielson Feminine Hygiene Product Safety
Act of 2017, H.R. 2379, 115th Cong. (2017); Tampon Safety and Research Act of 1999, H.R. 890,
106th Cong. (1999); Tampon Safety and Research Act of 1997, H.R. 2900, 105th Cong. (1997).
211. See KOHEN, supra note 101, at 29.
212. See, e.g., On Day of the Girl, supra note 24; Lauren Valenti, Why New York's Period
ProductLabeling Act Is So Important, VOGUE (Oct. 14, 2019), https://www.vogue.com/article/newyork-menstrual-period-product-labeling-act ("Women are thinking more critically and making more
informed decisions about menstruation.").
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State Menstrual Products Right to Know Acts

Due to the lack of action from the federal government regarding the
disclosure of ingredients in menstrual products, states have begun
passing legislation to require manufacturers to disclose the ingredients in
period products. 213 New York and California became the first two states
in the United States to pass legislation requiring period product
manufacturers to disclose the ingredients in their products. 214 In both
states, the legislatures passed the laws in order to protect the health of
people who experience periods.2 1
1. New York
In 2019, recognizing the danger women face from not knowing the
ingredients in their period products under current federal law, 216 New
York became the first state in the United States to require companies to
disclose the ingredients in their menstrual products. 2 17 On the International Day of the Girl, Governor Andrew Cuomo signed the New York
Menstrual Products Right to Know Act.2 18 Governor Cuomo expressed
the importance of requiring companies to disclose the ingredients in
menstrual products and stated, "[p]ractically every product on the market
today is required to list its ingredients, yet these items have inexplicably
evaded this basic consumer protection." 2 19
The New York State Assembly first recognized the danger the
undisclosed ingredients in period products create for women 220 and

213. See N.Y. GEN. Bus. LAW § 399-aaaa (McKinney 2020); Assemb. 1989, 2020 State
Assemb., Reg. Sess. (Cal. 2020).
214. See GEN. BUS. § 399-aaaa; Cal. Assemb. 1989.
215. See Menstrual Products Right to Know Act Signed by Governor, CAL. ST. ASSEMB.
DEMOCRATIC CAUCUS (Sept. 30, 2020), https://asmdc.org/press-releases/menstrual-products-right-

know-act-signed-governor; On Day of the Girl, supra note 24.
216. N.Y. St. Assemb., Assemb. 2019-164B, Reg. Sess. (N.Y. 2019).
217.

Jaramillo, supra note 16.

218. Id.
219. On Day of the Girl, supra note 24.
220. Assemb. 2019-164B. The New York State Assembly stated:
Tampons are marketed and sold with little or no data assuring the ingredients they
contain are safe. These products are intended for use on or in the extremely permeable
membranes of the vaginal area of a woman's body. Toxic and allergenic chemicals may

be contained in tampons, raising significant health concerns. Labeling of tampon
packages would serve to protect the public and allow consumers to make informed
decisions regarding the purchase of tampons.
Id. Assembly Member Linda B. Rosenthal spearheaded the law and stated, "[mlenstrual product
ingredient disclosure is a vital consumer empowerment tool, and will hold menstrual product
manufacturers to the highest level of accountability." On Day of the Girl, supra note 24.
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21
proposed the New York Menstrual Products Right to Know Act. The
222
requires "each
New York Menstrual Products Right to Know Act
package or box containing menstrual products sold in this state to
contain a plain and conspicuous printed list of all ingredients which shall
223
The purpose of the law was to
be listed in order of predominance."
"empower women to make decisions about what goes into their

bodies."224
Regarding the ingredients in period products, the New York
Menstrual Products Right to Know Act requires menstrual product
companies to disclose the added ingredients in their products. 225
Moreover, the law imposes a penalty on companies that do not comply
with the requirement. 226 The pertinent portion of the statute states:
1. For purposes of this section:
(a) "ingredient" shall mean an intentionally added substance present in
the menstrual product;
(b) "menstrual product" shall mean products used for the purpose of
catching menstruation and vaginal discharge, including but not limited
to tampons, pads, and menstrual cups. These products may be either
disposable or reusable.
2. No later than eighteen months after this section shall have become a
law, each package or box containing menstrual products sold in this
state shall contain a plain and conspicuous printed list of all ingredients
which shall be listed in order of predominance. Such list shall either be
printed on the package or affixed thereto.
3. The requirements of this section shall apply in addition to any other
labeling requirements established pursuant to any other provision of
law.
4. Whenever a violation of this section has occurred, a civil penalty of
one percent of the manufacturer's total annual in-state sales not to
exceed one thousand dollars per package or box shall be imposed on
227
the manufacturer.

221. N.Y. GEN. Bus. LAW
222. Id.
223.

§ 399-aaaa (McKinney

2020).

Id.; New York Requires Disclosure of Ingredients in Menstrual Products, THE NAT'L L.

REv. (Oct. 16, 2019), https://www.natlawreview.com/article/new-york-requires-disclosureingredients-menstrual-products.
224. On Day of the Girl, supra note 24 ("[E]very single New Yorker who uses tampons and
pads will know exactly what's in the products they use in and on some of the most sensitive parts of
their bodies for 24 hours a day, seven days a week, one week out of the [sic] for as many as 40
years.").

225. See GEN. BUs.
226. See id.
227. Id.

§ 399-aaaa.
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The New York law is regarded as the current industry standard for
ingredient disclosures. 2 2
Although the New York law requires menstrual product manufacturers to disclose ingredients in menstrual products, the law leaves the
requirements open for interpretation. 229 Unlike the labeling requirements
for TSS and absorbency levels, 230 there is no standard form period
product manufacturers must follow when labeling menstrual products
with ingredients. 231 Furthermore, it is unclear from the definition of
"ingredient" whether menstrual product manufacturers have to test their
products in order to discover all of the ingredients in their products, like
dioxins or pesticides. 232 Therefore, although the New York Menstrual
Products Right to Know Act requires menstrual companies to disclose
the ingredients in their products, 2 3 the broad language of the law creates
the risk that some ingredients may continue to remain undisclosed. 234

2. California
More recently, California adopted a similar law requiring period
product manufacturers to disclose the ingredients in their products. 235 On
September 29, 2020, California Governor Gavin Newsom signed the
Menstrual Products Right to Know Act of 2020.236 Similar to New York,
California recognized the danger women face for not knowing the
228. See Erin Bunch, California Is About to Become the Second State Requiring Ingredient
Transparency
in
Period
Products,
WELL
+
GOOD
(Sept.
8,
2020),

https://www.wellandgood.con/period-product-transparency.
229.

See New York Requires Disclosure of Ingredients in Menstrual Products, supra note 223

("The law itself is exceedingly short, leaving open questions, including but not limited to,
determining those entities responsible for product labeling and confirming whether ingredient
identities can be protected as confidential.").

230.

See 21 C.F.R.

§ 801.430 (2020) (stating the labeling

requirements for TSS and absorbency

levels on tampon boxes).
231. See New York Requires Disclosure of Ingredients in Menstrual Products, supranote 223.

232. See id. ("[T]he requirement to disclose only intentionally added substances seemingly
limits the ingredient disclosure requirement.").

233. See N.Y. GEN. BUS. LAw
234.

§ 399-aaaa (McKinney

2020).

See New York Requires Disclosure of Ingredients in Menstrual Products, supra note 223

("[T]erms such as 'plain and conspicuous' and 'listed in order of predominance' are amenable to
interpretation and require guidance and stakeholder engagement to effectuate legislative intent.").

235.
236.

See Assemb. 1989, 2020 State Assemb., Reg. Sess. (Cal. 2020).
See id. Assembly member Cristina Garcia was a main advocate for the legislation. See

Menstrual Products Right to Know Act Signed by Governor, supra note 215 ("'Consumers in

California have a right to know what is in the products they will be using for over 40 years of their
life, in order to protect their health.' Garcia continued, 'My goal with this law is to increase the
awareness of the toxic chemicals currently in our menstrual products. It was troubling at best to
learn that products people rely on contain Phthalates, Bisphenols, Parabens, and PFAS/PFOA,
which all have been found to be harmful to human health. Periods are not a luxury and people
should have the knowledge to make safer choices."').
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ingredients in their period products and passed this legislation to allow
women to make safer, more informed choices when choosing their
period products.2 37
The California law requires menstrual product manufacturers to
label "a package or box containing menstrual products" with "all of the
ingredients in the product." 2 8 Under the California law, the definition of
ingredients is broader than the New York Menstrual Products Right to
Know Act. 2 9 Critics argue that the California definition of ingredients
falls below the industry standard.240 The California law does not require
manufacturers to disclose certain dangerous added fragrances. 241
Notably, under the California Menstrual Products Right to Know Act,
manufacturers are not required to disclose two "problematic allergens
242
The law also allows
known to cause genital contact dermatitis."
ingredients that are classified as "confidential business information" to
43
remain undisclosed to the consumer. 2 There is no guarantee that the
ingredients excluded under the disclosure exceptions will not create
health risks for menstruators. 2 4 Therefore, even though the California
law on its face requires manufacturers to disclose all of the ingredients in
237.

See Menstrual ProductsRight to Know Act Signed by Governor, supra note 215.

238. Cal. Assemb. 1989 § 111822.2(a).
239. See id. § 111822(d) ("'Ingredient' means a fragrance ingredient or other intentionally
added substance or combination of substances present in the menstrual product, unless the
intentionally added substance or combination of substances is confidential business information, in
which case the manufacturer may identify the ingredient by its common name to protect its
confidential identity .... ").
240.

See Bunch, supra note 228.

241. See id. ("[T]he bill allows for added fragrance which falls under a certain threshold to be
left off of ingredients lists, so California consumers will remain unaware of their inclusion in
products. 'This is concerning because these are products that are coming into contact with sensitive,
absorptive tissue, and even fragrance ingredients below 100 parts per million could pose some
health concerns."'); Press Statement: Women's Voices for the Earth'sStatement on the Passing of
California's AB 1989, Period Product Ingredient Disclosure Bill, WOMEN's VOICES FOR THE

EARTH (Sept. 30, 2020), https://www.womensvoices.org/2020/09/30/statement-passing-of-abl989period-product-ingredient-disclosure-bill [hereinafter Press Statement] ("AB 1989 also puts
alarming restrictions on fragrance disclosure by only requiring disclosure above a 100ppm
threshold. Fragrance can contain toxic ingredients, and considering the use of these products in the
vagina and on sensitive vulvar tissue, this is information people who menstruate have a right to
know, no matter the level.").

242. Press Statement, supra note 241 ("Methylisothiazolinone (MI) and the combination of
Methylchloroisothiazolinone/methylisothiazolinone (MCI)-do not need to be disclosed under AB
1989. Studies show that these allergens are commonly used as preservatives in adhesives like the
kinds used on menstrual pads. This is the type of information that should require disclosure, instead
AB 1989 will allow corporations to continue to withhold this information from the public.").
243. See id.; Cal. Assemb. 1989 § 111822(c)(1)(A) ("'Confidential business information'
means an intentionally added ingredient or combination of ingredients for which a claim has been
approved by the federal Environmental Protection Agency for inclusion on the Toxic Substances
Control Act (TSCA).").
244.

See PressStatement, supra note 241.
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period products, the law includes significant exceptions to the disclosure
requirements that pose health risks for the consumers who use the
products. 2 4
Furthermore, similar to the New York law, 2 46 the California law
requires manufacturers to label period products with a conspicuous list
of all ingredients in order of predominance by weight. 24 7 In addition to a
label on the physical period product container, the California law also
requires manufacturers to provide a list of ingredients on their
website. 248 This allows the manufacturers' disclosures to be more readily
available to the public. 249 Moreover, the California law provides
guidance for period product manufacturers to follow when there is a
change to the ingredients in their products. 5 0
The most significant difference between the California and New
York Menstrual Products Right to Know Acts is that the California law
does not have a separate penalty for manufacturers that do not comply
with the law.251 Unlike the industry standard, period product manufacturers that do not comply with the disclosure requirements of the
California law will not be uniformly sanctioned. 22 Ultimately, the
disclosure requirements under the California Menstrual Products Right
to Know Act are less comprehensive than the industry standard set forth
in the New York Menstrual Products Right to Know Act. 3

See id.; Cal. Assemb. 1989 § 111822(c)(1)(A).
246. See N.Y. GEN. BUS. LAW § 399-aaaa (2) (McKinney 2020).
247. Cal. Assemb. 1989 §§ 111822.2(a)-(b) ("A package or box containing menstrual products
that was manufactured on or after January 1, 2023, for sale or distribution in this state shall have
printed on the label a plain and conspicuous list of all ingredients in the product. The ingredients
shall be listed in order of predominance by weight in the menstrual product, except ingredients
present at a weight below one percent may be listed in any order following the other ingredients.
Ingredients shall be identified using a standardized nomenclature."). Unlike the California law, the
New York Menstrual Products Right to Know Act does not contain a nomenclature requirement for
245.

manufacturers to follow when disclosing ingredients. See California Passes Menstrual Products
Right
to
Know
Act,
BUREAU
VERITAS
(Oct.
1,
2020),

https://www.cps.bureauveritas.com/newsroom/california-passes-menstrual-products-right-know-act.
248. Cal. Assemb. 1989 § 111822.2(c).
249. See Bunch, supra note 228.
250. Cal. Assemb. 1989 §§ 111822.4(a)(b).
251. See Cal. Assemb. 1989.
252. See id.; N.Y. GEN. Bus. LAW § 399-aaaa (McKinney 2020).
253. See GEN. Bus. § 399-aaaa; Cal. Assemb. 1989. The downfalls of the California Menstrual
Products Right to Know Act have been attributed to the corporate influence over the legislature's
decision making. Press Statement, supra note 241.
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The U.S. House ProposedFederalMenstrualProductsRight to
Know Act

In 2019, the U.S. House introduced a bill that would require
companies to disclose and label menstrual products with all of their
ingredients.2 4 This was not the first time the U.S. House attempted to
introduce such a bill.2 55 In the past, the U.S. House has shown concern
for the risks of the undisclosed ingredients in period products. 256
Consequently, the U.S. House proposed to enable multiple programs
researching the presence and effects of dangerous toxins in period
products.2 5 7 Yet, none of the proposed bills have made it out of a U.S.
House Committee or Subcommittee.2 5 8
Recognizing the dangers period products create for people who
menstruate, the U.S. House proposed a bill titled the Menstrual Products
Right to Know Act of 2019 to amend section 502 of the Federal Food,
Drug, and Cosmetic Act. 259 Section 502 concerns misbranded drugs and
devices.2 60 Therefore, under the proposed legislation, if a period product
manufacturer does not label the ingredients in their products, the
26
violation is treated as a misbranded product. 1The relevant portion of
the statute states:
[A drug or device shall be deemed to be misbranded] [i]f it is a
menstrual product, such as a menstrual cup, a scented, scented
deodorized, or unscented menstrual pad or tampon, a therapeutic
vaginal douche apparatus, or an obstetrical and gynecological
device described in . .. [the] Code of Federal Regulations (or
any successor regulation), unless its label or labeling lists the
name of each ingredient or component of the product in order of

254. Menstrual Products Right to Know Act of 2019, H.R. 2268, 116th Cong. (2019).
255. See Menstrual Products Right to Know Act of 2017, H.R. 2416, 115th Cong. (2017). The
bill was introduced in the U.S. House on May 12, 2017. Id. The bill was then referred to the U.S.
House Committee on Energy and Commerce and then referred to the U.S. House Subcommittee on
Health. Id. The bill never made it out of the U.S. House Subcommittee. See id.
256. See Robin Danielson Feminine Hygiene Product Safety Act of 2017, H.R. 2379, 115th
Cong. (2017); Tampon Safety and Research Act of 1999, H.R. 890, 106th Cong. (1999); Tampon
Safety and Research Act of 1997, H.R. 2900, 105th Cong. (1997).
257. See H.R. 2900; H.R. 890; H.R. 2379.
258. See H.R. 2900 (stating the last action was on November 14, 1997, when the bill was
referred to the U.S. House Subcommittee on Health and Environment); H.R. 890 (describing the last
action taken on the bill as the sponsor's introductory remarks on June 23, 1999); H.R. 2379
(explaining the last action on the bill occurred on May 5, 2017, when it was referred to the U.S.
House Subcommittee on Health).
259. Menstrual Products Right to Know Act of 2019, H.R 2268, 116th Cong. (2019).
260. See 21 U.S.C. § 352 (2018).
261. See H.R 2268.

https://scholarlycommons.law.hofstra.edu/hlr/vol49/iss4/6

28

Clancy: Knowledge Is Power: The Federal Government Must Require Companies

2021 ]

KNOWLEDGE IS POWER

1079

the most predominant ingredient or component to the least
predominant ingredient or component. 262
Unlike the New York Menstrual Products Right to Know Act, the
federal Menstrual Products Right to Know Act of 2019 does not include
a separate provision that enforces the labeling requirements.2 63 Rather, a
violation of this bill follows the procedures of a misbranded medical
device. 2' The FDA's enforcement against individuals for misbranded
products varies depending on "the nature of the violation." 265 The
sanctions vary in severity and can include a warning letter, 2 66 seizure, 2 67
injunction, 268 criminal prosecution, 2 69 and/or criminal fine. 2 70 Therefore,
under the proposed federal law, the FDA will enforce violations on a
case-by-case basis, and there is no uniform enforcement policy for
manufacturers that violate the disclosure requirements.2 71

262. Id.; 21 U.S.C. § 352.
263. See H.R. 2268; N.Y. GEN. BUS. LAW § 399-aaaa (McKinney 2020).
264. See H.R. 2268.
265. Types of FDA Enforcement Action, U.S. FOOD & DRUG ADMIN. (Nov. 6, 2017),
https://www.fda.gov/animal-veterinary/resources-you/types-fda-enforcement-actions.
266. Id. ("Warning Letters are sent to the individuals or firms, advising them of specific noted
violations. These letters request a written response as to the steps which will be taken to correct the
violation.").
267. Id. ("An action brought against an FDA-regulated product because it is adulterated and/or
misbranded within the meaning of the Act. The purpose of such an action is to remove specific
violative goods from commerce.").
268. Id. ("An order by a court that requires an individual or corporation to do or refrain from
doing a specific act. FDA may seek injunctions against individuals and/or corporations to prevent
them from violating or causing violations of the Act.").
269. Id. ("Criminal prosecution .. . may be recommended in appropriate cases for violation of
[s]ection 301 of the Act; [m]isdemeanor convictions, which do not require proof of intent to violate
the Act, can result in fines and/or imprisonment up to one year. Felony convictions, which apply in
the case of a second violation or intent to defraud or mislead, can result in fines and/or
imprisonment up to three years. The FDA field offices have primary responsibility for conducting
inspections or investigations and collecting samples which may lead to recommendations for
enforcement/regulatory action. The type of action recommended will depend upon the nature of the
violation and the public health concern, Agency policy, previous history of violations by the firm,
and other factors.").

270. Id. ("Misdemeanor fines under the Act may reach $500,000 under some circumstances.
The Criminal Fine Enforcement Act of 1994 (Public Law 98-596) provides for fines for violations
of Federal law. Although it is not part of the Act, the Criminal Fine Enforcement Act of 1994
applies to all fines levied under the Act, as well as other statutes that contain provisions enforced by
FDA. The following fines are applicable for each offense: [u]p to $100,000 for a misdemeanor by
an individual that does not result in death; [u]p to $200,000 for a misdemeanor by a corporation that
does not result in death[; u]p to $250,000 for a misdemeanor by an individual that results in death,
or a felony[; u]p to $500,000 for a misdemeanor by a corporation that results in death, or a felony.
The maximum imprisonment for a misdemeanor under the Act remains a year for each offense.").
271. See id.
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Another shortfall is that the bill does not include a definition of
272
ingredients that period product manufacturers must disclose. Both the
New York and California laws include a section that defines the

ingredients in period products that must be disclosed under the
respective laws. 27 3 Therefore, the federal Menstrual Products Right to
Know Act of 2019 is an inadequate bill to protect menstruators, because
it does not have a definite enforcement mechanism, and the language is
vague.274 The U.S. House Menstrual Products Right to Know Act has yet
to make it out of the House Energy and Commerce Subcommittee on
Health.2 7s
IV.

A CHANGE TO EMPOWER MENSTRUATORS

Currently, under the Federal Food, Drug, and Cosmetic Act, people
do not know the ingredients in their period products because they are
classified as medical devices. 276 As a result, people continue to use
menstrual products without knowing the associated health risks because
277
companies are not required to disclose the information in the products.
This Note takes the position that a federal approach is necessary to
ensure that all people who menstruate know every ingredient in their
menstrual products. 278 The solution to this problem is to amend the
Federal Food, Drug, and Cosmetic Act to require period product
manufacturers to label all ingredients in their products, include a
warning of the associated health risks, and impose a clear penalty on
279
manufacturers who violate the disclosure requirements.
Subpart A argues the necessity for a federal approach to the
problem. 280 Subpart B sets forth the ingredient disclosure requirements
menstrual product manufacturers must follow when labeling all
menstrual products.2 81 Unlike the current federal legislation proposed in
the U.S. House, this solution will clearly define what manufacturers

272. See Menstrual Products Right to Know Act of 2019, H.R. 2268, 116th Cong. (2019).
273. See N.Y. GEN. BUS. LAW § 399-aaaa (McKinney 2020); Assemb. 1989, 2020 State
Assemb., Reg. Sess. (Cal. 2020). Albeit, the clarity of these definitions is criticized. See Press
Statement, supra note 241; New York Requires Disclosure of Ingredients in Menstrual Products,
supra note 223.

274. See H.R. 2268.
275. See id.
276.

SCRANTON, supra note 2, at 8.

277.
278.
279.
280.
281.

Wendee, supra note 73, at A74.
See infra Part I.A-B.
See infra Part I.A-B.
See infra Part IV.A.
See infra Part IV.B.
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must disclose in order to comply with the proposed amendment. 282
Subsequently, Subpart C discusses the importance of labeling period
products with a warning of the health risks associated with dangerous
ingredients in the products. 283 Finally, Subpart D sets forth a clear,
uniform penalty for manufacturers who violate the disclosure
requirements. 284 In order to best protect people who menstruate from the
serious risks of not knowing the ingredients in their menstrual products,
it is important to have clear ingredient disclosure requirements with a
label of their health risks and a uniform sanction for violations. 285
A.

A FederalApproach

Due to the severity of the issue, 286 a federal approach is necessary
to ensure that all people who menstruate are able to choose products that
are safe for their body. 287 This would not be the first time that the FDA
required manufacturers to disclose ingredients in products. 2 88 Under the
Federal Food, Drug, and Cosmetic Act, the FDA requires food and other
products to be labeled with their ingredients. 289 These requirements have
been implemented for consumer safety. 290 Thus, due to the health risks
people who menstruate face from using menstrual products, 291 period
product manufacturers must be required to disclose the ingredients in
their products for consumer safety. 292
Some critics argue that a federal approach is not necessary because
once period product manufacturers change their labeling to conform
with the New York Menstrual Products Right to Know Act, they will use
the same packaging with the disclosed ingredients in every state. 293 This
282.
283.
284.
285.
286.

See infra Part IV.B.
See infra Part IV.C.
See infra Part IV.D.
See infra Part IV.B-D.
See supra Part II.B.1-2.

287.
288.

See SCRANTON, supra note 2, at 18.
See, e.g., U.S. FOOD & DRUG ADMIN., A FOOD LABELING GUIDE: GUIDANCE FOR

INDUSTRY
5
(2013),
https://www.fda.gov/files/food/published/Food-Labeling-Guide%28PDF%29.pdf.
289. See id.; U.S. FOOD & DRUG ADMIN., supra note 177; Letter from Women's Voices for the
Earth to Members of Congress, supra note 114 ("Ingredient listings are required for food,
cosmetics, and over the counter drugs enabling the public to avoid ingredients they are concerned
about, or that may cause allergic reactions like rashes, itchiness or burning.").
290. See U.S. FOOD & DRUG ADMIN., supranote 177.
291. See supra Part I1.B.1-2.
292. See infra Part IV.B.
293. See Bunch, supra note 228 ("[I]t will be interesting to see what happens as the New York
law goes into effect next year, as it's not exactly cost effective for companies to print different
packaging for different states-meaning that hypothetically, New York's comprehensive law could
be the tide that rises all boats by forcing transparent packaging into every market. For this reason,
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is largely attributed to the fact that it could be costly to manufacture
2 94
different packages depending on the state in which the product is sold.
Therefore, in theory, through the New York law, period product
manufacturers could disclose ingredients on all of their products across
295
the nation without a federal law mandating the disclosure.
However, there is no guarantee that the cost of ingredient disclosure
will be significant enough to encourage manufacturers to disclose all
ingredients on menstrual product containers in every state, including
296
states that do not have a law mandating the disclosure. Moreover, the
2 97
New York and California laws have different disclosure requirements.
In these states alone, period product manufacturers will have to make
different disclosures on their products.298 A federal approach would
provide uniform disclosures and eliminate the need for manufacturers to
make different ingredient disclosures depending on the state in which the
product is sold. 299
B.

Companies Must Disclose All Ingredientsin Menstrual Products

The Federal Food, Drug, and Cosmetic Act should be amended to
adopt language requiring companies to disclose all ingredients in
menstrual products and label the products with their ingredients. 300
Currently, under the Federal Food, Drug and Cosmetic Act, menstrual
products are classified as medical devices and, therefore, companies are
not required to label or disclose the ingredients in these products that
30 t
create dangerous health risks for menstruators. 1 It is clear from medical
studies that period products contain dangerous ingredients that pose
serious risks to menstruators' health. 302 Therefore, for their safety,
people who menstruate have a right to know the ingredients that are
entering into their bodies. 303 For this solution to be effective, the

she says, the industry may yet try to fight what's happening in New York and then do the same on
the West Coast, too.").
294. See id.
295. See id.
296. See id.
297. See id.
298. See id.
299.

See SCRANTON, supra note 2, at 18.

300. See Menstrual Products Right to Know Act of 2019, H.R. 2268, 116th Cong. (2019)
(proposing an amendment to the Federal Food, Drug, and Cosmetic Act that would treat menstrual
products as misbranded if they are not labeled with their ingredients).
301. See supraPart II.A.1-2.
302. See supraPart II.B.1-2.
303.

See Press Statement, supra note 241.
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"

amendment must provide clear guidance for the disclosure requirements
under the law.304
The definition of "ingredient" is the most crucial piece of the
amendment because it is important to ensure that all ingredients,
including the most dangerous ones, are disclosed.3 0 The U.S. House,
New York, and California Menstrual Products Right to Know Acts are
instructive in crafting an amendment to the Federal Food, Drug, and
Cosmetic Act. 306 Regarding the definition of ingredients, under the
proposed U.S. House Menstrual Products Right to Know Act of 2019,
there is no definition of the ingredients that must be disclosed.307
Moreover, the California Menstrual Products Right to Know Act's
definition of "ingredients" is insufficient because it allows
manufacturers to omit certain dangerous ingredients. 308 Finally, the New
York Menstrual Products Right to Know Act is regarded as the current
industry standard for disclosing ingredients in menstrual products, but
the law still contains vague language. 30 9 In order for the amendment to
serve its purpose in allowing people to know all ingredients in their
period products, the definition of "ingredients" must include all
ingredients without any exceptions.3 1 0 Therefore, "ingredients" should
be defined as, "something that enters into a compound or is a
component part of any combination or mixture." 31
Similar to the FDA requirement that tampon manufacturers must
test the absorbency level of tampons, the amendment should require
manufacturers to test the ingredients in their products.312 Uniform testing
procedures would ensure that all ingredients are disclosed. 3 Unlike the
FDA testing requirements for absorbency levels, the ingredient test
results should be made available to the public on the company's
304.
305.
306.

See id.
See supra Part III.B-D.
See supra Part 1II.B-D.

307.

See supra Part III.D.

308.
309.

See supra Part III.C.2.
See supra Part III.C.1.

310.

See New York Requires Disclosureof Ingredients in MenstrualProducts, supra note 223;

Press Statement, supra note 241 ("New York's ground-breaking law, and-while flawed-AB
1989, are both clear examples that keeping ingredient secrets, especially in products that come into
such intimate contact with the body, is simply not acceptable."). The California Menstrual Products
Right to Know Act allows exceptions for confidential business information and certain added
fragrances. See Assemb. 1989, 2020 State Assemb., Reg. Sess. (Cal. 2020). The New York
Menstrual Products Right to Know Act only includes intentionally added substances, which allows
certain ingredients to be excluded. See N.Y. GEN. BUS. LAW § 399-aaaa (McKinney 2020).
311.

See

Ingredient,

MERRIAM-WEBSTER,

https://www.merriam-

webster.com/dictionary/ingredient (last visited Aug. 1, 2021).
312. See supra Part III.B.
313. See supra Part II.B.
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website. 314 In employing this definition and testing requirement, it will
be difficult for period product manufacturers to hide the potentially
dangerous ingredients that are not intentionally added that remain
15
undisclosed under the current industry standard.
In addition to defining "ingredients," other pieces of the
16
amendment require definitions.3 The state Menstrual Products Right to
3 17
Know Acts are instructive in defining these key terms. In conjunction
with defining the ingredients that must be disclosed in menstrual
products, the amended law should describe the nature of the language
318
In this respect, the California law is
that manufacturers shall use.
Menstrual Products Right to
California
the
Modeling
319
instructive.
nomenclature to
standardized
use
must
Know Act, manufacturers
identify ingredients so that they are easy for the consumer to
understand. 320
Moreover, following the industry standard set forth in New York
law, menstrual products should be defined as "products used for the
purpose of catching menstruation and vaginal discharge, including but
not limited to" tampons, pads, menstrual cups, menstrual discs, and
321
period panties. "These products may be either disposable or reusable."
Finally, the amendment should include a procedure for manufacturers to
322
follow when an ingredient changes in a period product. This procedure should model the California law, which sets forth a procedure for
both changes to the physical label of the menstrual product and to the
manufacturer's website. 323 These definitions are important to ensure that

314. See supraPart III.C.2.
315. See supra Part II.B.1.
316. See Assemb. 1989, 2020 State Assemb., Reg. Sess. (Cal. 2020); N.Y. GEN. Bus. LAW
§ 399-aaaa (McKinney 2020).
317. See Cal. Assemb. 1989; GEN. Bus. § 399-aaaa.
318. See Cal. Assemb. 1989.
319. See id.
320. Id. § 111822.2(b) ("Ingredients shall be identified by using a standardized nomenclature,
including, but not limited to, the International Nomenclature of Cosmetic Ingredients (INCI), the
Household Commercial Products Association's Consumer Product Ingredient Dictionary (HCPA
Dictionary), or common chemical name. If a standardized nomenclature does not otherwise exist for
an ingredient, a name established by the Center for Baby and Adult Hygiene Products (BAHP) shall
be used by all menstrual product manufacturers.").

321. See GEN. Bus. § 399-aaaa(b). This would also include period underwear and menstrual
discs. See supra Part II.A.2.
322. See Cal. Assemb. 1989 §§ 111822.4 (a)-(b).
323. See id. This part of the amendment would read:
(a) When a manufacturer is required to make a revision to information disclosed online
due to a change in a designated list or a change in an ingredient or addition of a new
ingredient, the manufacturer shall make the revision no later than six months after the
change or addition of the ingredient, or after the adoption of the revised designated list

https://scholarlycommons.law.hofstra.edu/hlr/vol49/iss4/6

34

Clancy: Knowledge Is Power: The Federal Government Must Require Companies
KNOWLEDGE IS POWER

2021 ]

1085

people who menstruate are aware of every ingredient, including potential
hazardous ingredients, that are found in their period products.3 2 4
Another important aspect of the proposed amendment is to require
uniform labeling standards. 325 Recognizing the health risks of tampons,
the FDA already requires uniform labeling and disclosures for a TSS
warning and absorbency levels on tampons. 326 Therefore, due to the
potential health risks created by all period products, the federal law
should require uniform labeling standards for ingredient disclosure.3 27
Regarded as the current industry standard,3 28 the language of the New
York Menstrual Products Right to Know Act is instructive in crafting the
labeling requirements. 329 The pertinent portion of the New York law
states that "each package or box containing menstrual products
sold . .. shall contain a plain and conspicuous printed list of all
ingredients which shall be listed in order of predominance." 330 Similar to
the California law, predominance should be defined as the weight of the
ingredient." In addition to labeling the products with their ingredients,
for clarity, the manufacturers should also post the list of ingredients to
their website.33 2 Requiring ingredient disclosures to be labeled on the
physical menstrual product packaging, as well as on the manufacturer's
website, would enable people who menstruate to have greater knowledge
about the ingredients in their menstrual products.333
C.

A Warning Label to Explain the Health Risks

It is important to label menstrual products with their ingredients in
order for people who menstruate to know the possible dangerous

by its authoritative body, unless a later effective date for changes to a designated list is
imposed by the relevant authoritative body.
(b) When a manufacturer is required to change the label on a menstrual product because

of a change in a designated list or a change to an ingredient or addition of a new
ingredient, the manufacturer shall make the change within 18 months of the change or
addition of the ingredient, or after the adoption of the revised designated list by its
authoritative body, unless a later effective date is imposed by the relevant authoritative
body.
Id.
324.
325.
326.
327.
328.
329.
330.
331.
332.
333.

See supra Part II.B.1-2.
See supra Part III.B.
See supra Part III.B.
See supra Part III.B.
Bunch, supranote 228.
See N.Y. GEN. Bus. LAW § 399-aaaa (McKinney 2020).
Id.
See Assemb. 1989, 2020 State Assemb., Reg. Sess. (Cal. 2020).
See id. § 111822.2(c).
See id.
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ingredients in these products. 334 However, from a label alone, people
who use menstrual products may not know the health risks associated
with these ingredients.33 The health risks from these ingredients can be
serious, and people who use these products have a right to be informed
of their risks.3 3 6 In order for people who use menstrual products to be
aware of the health risks associated with the dangerous ingredients in
these products, the amended federal law should require period product
manufacturers to include a warning on all menstrual products that
337
contain ingredients that are linked to negative health effects.
This would not be the first warning label required for menstrual
products. 338 Due to the severity of the health implications associated
with TSS, the FDA requires tampon boxes to contain a warning with the
39
health risks caused by TSS. 3 Certain dangerous ingredients in period
3 40
products create risks to menstruators' health in equal severity to TSS.
For example, dioxins, furans, and pesticides found in menstrual products
34
are all known to cause cancer in humans. 1 However, simply labeling
period products with these ingredients does not convey to the average
person the severity of the ingredients.342 Therefore, in addition to
labeling menstrual products with ingredients, the federal law must
require period product manufacturers to label products with a warning
explaining the health risks associated with the dangerous ingredients in
the products. 343 A warning label will ensure that people know the health
3
risks associated with the dangerous ingredients in period products. 4
D.

Penaltyfor Nondisclosure

In addition to clear disclosure requirements and a warning label, in
order for the amended federal law to be effective, it must include a
monetary penalty for companies that do not comply with these
requirements. 345 Currently, under the New York law industry standard,
companies who fail to comply with the requirements of the Menstrual
Products Right to Know Act receive a "civil penalty of one percent of
334.
335.
336.
337.
338.
339.
340.
341.
342.
343.
344.
345.

See supra Part IV.B.
See KOHEN, supra note 101, at 8.
See supra Part II.B.2.
See supra Part II.B.2.
See supra Part III.B.
See supra Part III.B.
See supra Part III.B.
See supra Part II.B.2.
See KOHEN, supranote 101, at 8.
See 21 C.F.R. § 801.430 (2020).
See KOHEN, supranote 101, at 8.
See N.Y. GEN. BUS. LAW § 399-aaaa(4) (2020).
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the manufacturer's total annual in-state sales not to exceed one thousand
dollars per package or box." 34 6 Moreover, under the federal Menstrual
Products Right to Know Act, there is no uniform penalty for violations
of the disclosure requirements. 347 Rather, the FDA assesses punishment
on a case-by-case basis.3 48 Therefore, in order for there to be a clear
penalty that is uniformly enforced, the amendment should be similar to
the penalty in the New York Menstrual Products Right to Know Act. 349
In the United States, the total sales for menstrual products in 2017
was $5.9 billion. 5 0 "In 2020, those numbers are expected to reach $6.2
billion" in the United States.351 The size of the industry should be taken
into consideration when crafting a penalty for the amended federal law
to ensure that companies comply with the requirements. 35 2 Thus, using
the New York law as guidance for developing a penalty for a violation
of the amendment, there should be a monetary penalty of a set
percentage of the manufacturer's total annual sales not to exceed one
thousand dollars per package. 533 This percentage should be large enough
to deter offenders from repeating a violation of the disclosure
requirements. 354 Ultimately, a significant enough penalty will give
period product manufacturers an incentive to comply with ingredient
disclosure requirements of the amended federal law, thereby
empowering people who menstruate to know all of the ingredients in
period products.3 5
V.

CONCLUSION

All people who menstruate have a right to know the ingredients in
the products that come into direct contact with their bodies.35 6 However,
in the United States, people who menstruate do not currently have this
right. 357 It is clear from medical research that some of the most popular
menstrual products contain harmful ingredients that are dangerous to

346.
347.
348.
349.

Id.
See Menstrual Products Right to Know Act of 2019, H.R. 2268, 116th Cong. (2019).
See supra Part III.D.
See GEN. Bus. § 399-aaaa.

350.

The Ultimate Guide to FeminineHygiene, supra note 3.

351.

Id.

352.

See Kenneth Mann, Punitive Civil Sanctions: The Middleground Between Criminal and

Civil Law, 101 YALE L.J. 1795, 1830 (1992).
353. See GEN. Bus. § 399-aaaa.
354. See Mann, supranote 352.
355. See id.
356. See On Day of the Girl, supra note 24.
357. See supra Part III.A.
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358
menstruators' health. These ingredients include dioxins, furans, and
pesticides, which are known to cause serious health problems, among
other things, cancer, infertility, reproductive toxicity, and endocrine
disruption. 359 With the health risks associated with ingredients in
0
menstrual products, 36 it is critical that people know the chemicals they
361
are putting into their body.
The solution to this problem is simple: require menstrual product
manufacturers to disclose the ingredients in their products and provide a
3 62
warning label stating the associated health risks. This solution is not
groundbreaking, in fact, the FDA has required similar disclosures for
3 63
other products that have direct contact with the body. Moreover, the
FDA already requires tampon manufacturers to warn users about the
health risks of TSS and the absorbency levels associated with tampon
usage. 3" Therefore, requiring menstrual product manufacturers to disclose the ingredients in their products and provide a warning is well
within the federal government's authority and would be another
365
important consumer safety measure to protect menstruators.
An amendment to the Federal Food, Drug, and Cosmetic Act will
allow all people who menstruate to gain the right to know exactly what
366
Under this amendment, period
ingredients are in period products.
disclose all of the ingredients
to
required
be
product manufacturers will
in their products, and provide a warning label with the associated health
risks, thereby giving people who menstruate the power to choose
367
Moreover,
products that are less likely to put their health at risk.
will
requirements
disclosure
the
with
manufacturers that do not comply
the
with
comply
receive a monetary penalty to incentivize them to
368

regulations.
The Federal Food, Drug, and Cosmetic Act was founded on
consumer protection, and as research develops, the legislation should be
369
amended to ensure the continued safety of all people who menstruate.

358. See supra Part II.B.1-2.
359. See supra Part II.B.1-2.
360. See supra Part II.B.2.
361.

See On Day of the Girl, supra note 24.

362.
363.
364.
365.
366.
367.
368.
369.

See supra Part IV.
See supra Part IV.A.
See supra Part III.B.
See supra Part IV.A.
See supra Part IV.B-D.
See supra Part IV.B-D.
See supra Part IV.D.
See supra Part III.A.
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With over twenty-six percent of the world being of reproductive age,37 0
this amendment could prevent a loved one from one day experiencing
cancer or some other serious health condition resulting from period
product use. 37' In summation, it is left in the hands of the United States
Congress to empower all people who menstruate with the knowledge of
the ingredients they are putting in their bodies, so they can make
educated, safer choices when choosing their period products. 72
HaleyE. Clancy*

370. See Fast Facts: Nine Things You Didn't Know About Menstruation, UNICEF (May 25,
2018),
https://www.unicef org/press-releases/fast-facts-nine-things-you-didnt-know-aboutmenstruation#:~:text=Menstruation%20is%20stigmatized%20all%20over%20the%20world.&text=
Roughly%20half"/o200f%20the%20female,about%20two%20to%20seven%20days. Although there
are a vast number of individuals who menstruate, there is still a major problem with access to period
products. Id. For a comprehensive discussion on the period product access crisis, see The Ultimate
Guide to Feminine Hygiene, supra note 3.

371. See supraPart II.B.
372. See supra Part IV.
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